incivo works by stopping the virus from multiplying and infecting new recruits . incivo is used to treat hepatitis c infection in adults and adolescents ( 18 years of age and older ) who are already taking peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . the ns3 -- 4a enzyme is essential for the hepatitis c virus to multiply and infect new recruits who are also taking peinterferone alfa and ribavir . incovis is used in adults who have previously taken an interferon - based regimen .
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been prescribed peginterferon alfa or ribavirin in addition to incivo . if you cannot take their contraceptives ( e . g . pregnancy precautions ). warnings and precautions talk to your doctor or pharmacist before taking incivo , if you : have previously been prescribed pginterfon alffa or are currently being treated with ribavir . if any of these apply to you , tell your doctor before taking this medicine . if your doctor has prescribed
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose regimen is one tablet once a day . the recommended dosage regimen is 3 mg twice a day ( 6 mg twice daily ) taken with 2 or 8 doses per day ( 8 mg twice weekly ). your doctor will determine the dose that is right for you . this is because both hepatitis c virus infection and human immunodeficiency virus infection are caused by the same type of efavirenz . your doctor may prescribe the recommendeddose regimen based on the following : 3 mg once a daily
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may be serious and needs immediate medical attention . other symptoms of the rash include : a severe skin reaction . tell your doctor immediately if you develop a skin rash . your doctor may decide to treat your rash with other medicines . other signs of a rash include fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash , peeling skin , fever , flu - like symptoms , painful skin blisters
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telaporir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbenbryt contains the active substance daclizumab beta , a monoclonal antibody . what zinbaq is used for zinbinbrytta is used to treat multiple sclerosis in adults . it is used as therapy , followed by two ms treatment and other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms and repeated attacks ( relapses ). symptoms that occur after a relapse are called myelin and can
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems , tell your doctor before taking zin bryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell the doctor before you take zirinbrya . if your doctor has told you that you are taking any other medicines , including herbal supplements . if this applies to you ( or you are not sure ), tell your physician before taking any medicines , particularly supplements
your doctor or nurse will give you zinbryta exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much zinbaq is given the usual dose of zin bryta is 150 mg . your doctor will ask you to have a blood test to check how well your liver is working . your dose of the first dose of your first dose will be calculated by your doctor . your second dose of a dose of one dose of two doses of zinfryta will be given at a dose ranging from 40 mg to 40 mg . this blood test will be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affects up to 1 in 100 people ) severe inflammation of the liver may lead to death . tell your physician
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to store it in the original package . zin bryta syringes / pens may be stored for a maximum of 30
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bryta contain sodium '). what zinbaryta looks like and contents of the pack zinbarryta is a clear to slightly yellow , colourless solution for injecting into a syringe / pen . it
what wilzin is wilzin belongs to a group of medicines called metabolism products . what wilson ' s disease is wilson is due to a rare inherited defect in copper excretion , which affects the liver , eyes and brain . this can lead to liver damage and neurological disorders . what is wiltin used for wilzin works by attaching to copper in the intestine and its further accumulation in the body . what it is used for the treatment of wilson s disease ? this treatment is for adults .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent called penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents such as penicillinamine . your symptoms will improve after the treatment has been started . monitoring 25 if insufficient treatment ( copper excess ) is required
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : the usual dose is 25 mg / 50 mg once a day . this dose is 1 mg / day . wilzin 50 mg / 2 mg once daily . this dosage is 1 to 6 mg / m2 . wilz 25 mg : once daily , this dose will be 1 mg . wilzan 50 mg : one daily dose will normally be 2 mg / kg . this will be one mg / dl . the usual starting dose is wilzin 25 mg once
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): very common : may affect more than one in 10 people not known : frequency cannot been estimated from available data . very rare : may affects lessthan 1 user
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do this after the first opening of the blister . donot store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of zinc acetate dihydrate ). each capsule contains 50 mg of the active substances ( equivalent of zinc , equivalent to 167 . 84 mg of Zinc acetates dihydrated ). the other ingredients are magnesium stearate . the capsule shell contains gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , printed with " wilzin 50 mg
biktarvy contains the active substances bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor , emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor , nrti ) tenofovir alafenamide , an antiiretraviral medicine called a nucleotide reverse transcriptases inhibitor ( nrtti ) biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the amount of hiv in
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these : - rifampicin which is used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help prevent depression and anxiety . warnings and precautions talk to your doctor before taking biktorvy if : you have liver problems . this is because biktor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements . your daily dose should be adjusted with vitamins such as magnesium and iron . see section 2 " taking these medicines with biktarvy ". if you take more biktorvy than you should if you accidentally take
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that may have no obvious symptoms . autoimmune disorders ( when the immune system attacks healthy body tissue ) are a common complication of medicines used to treat hiv illness . autoimmune conditions occur many months after treatment
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktorvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravor , 200 mg emtritabine , tenofovel ( fumarate equivalent to 25 mg tenofofovira alafeneamide ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171
novondorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2 diabetic in adults . treatment is usually started by diet and exercise and weight reduction . your blood blood sugar may also be increased when you start taking novonere or metformin . if you have diabetes , novonor may lower the
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis ( see section 4 ). if your doctor has told you that you have a severe liver disease . if your dose of gemfibrozil ( a medicine used to lower increased fat levels in the blood ) is too high . warnings and precautions 47 if you know that you may have liver problems , novonors should not be used in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the usual starting dose is 30 mg once daily for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks . if you take more novonor than you should if you accidentally take too many tablets , contact your doctor . your blood sugar may go up ( see section " taking novonors "). if you have taken
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , hypoglycemic reactions are generally mild / moderate . hypoemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect up to one
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) only in 1 mg and iron oxide red ( e 172 ) only only in 2 mg . what novonor looks like and contents of the pack novonere tablets are white , round , flat , embossed with " pfizer "
pumarix is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemic fluids are similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of ovalbumin ( as formaldehyde and sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop using the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarip is not recommended . if this vaccine is not fully effective 33 talk to your doctor or nurse before using pumarax . if
pumarix is intended for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to h5ns1 . it is intended to be given to children aged 18 - 49 years . pumix is given as a single dose . the recommended dose is one vaccine . pumanix is used in children 3 - 9 years of age and adolescents 3 - 17 years of ages . how pumarik is given pumarax is given by injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may be severe and may lead to dangerously low blood pressure , shock and need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection has been injected fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where the site
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the vaccine in the original package in order to protect from light . after preparation of the suspension , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with the
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which is used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water and water for injections . what pumarax
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . when used in combination with gallium (" 68ga ") edotreaotide , this procedure is performed by a doctor or nurse . the doctor or a nurse will inject gallium / edotreeotide into a vein or body areas . somakit to is used for a medical imaging procedure called positron emission tomography ( pet ) in adults . this medical procedure is to obtain images of the abnormal cells and tumours in your disease . the
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have experienced allergic reaction to any of these ingredients ( listed under section 4 ) warnings and precautions talk to your doctor before taking somaknittoc if : you have kidney or liver problems you have renal or hepatic disease you are under 18 years of age . you are suffering from dehydration . the examination will be repeated every 28 days . you have or have had others medical conditions that affect the way your body works ( e . g . cushing syndrome , inflammation of thyroid
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions . they are responsible for the correct disposal of the product and for the safe disposal of any unused product . they should not use somakiton to treat or prevent contamination . 29 the nuclear medicine doctor supervising the procedure will decide the quantity of somakitas to be administered . the usual dose is 100 to 200 megabecquerel per kilogram of body weight . the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakit : allergic reactions ( hypersensitivity ) have been reported with somackittoc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . this is due to ionising radiation ( a type of radiation that can cause cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : somakit t must be stored at a temperature not above 4 ºc and below 25 ºcs . do not freeze . do away with the solution if you notice visible signs of deterioration of radioactive products .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotREotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium for radiolabelling . the solution contains hydrochloric acid . what somakiton t looks like and contents of the pack somakt t is a white powder for solution for injection in a glass vial with yellow flip - off cap . it is a clear and colourless solution
afinitor is an anticancer medicine that contains the active substance everolimus . everolim slows down the growth of cancer cells and helps them to grow . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women , when non - steroidal aromatase inhibitors ( such as nsh inhibitors ) have been shown to have been unsuccessful in keeping the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroid aromase inhibitor ) with hormonal anticancer therapy to treat advanced tumours called neuroendocrine tumours ( tumours
do not take afinitor if you are undergoing cancer treatment . do not take the combination of afincer with everolimus , sirolimus or temsirolimu in one dose . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking afiner : if you have any problems with your liver . if any disease affects your liver , your doctor may prescribe a different dose of afrinitor . if your doctor has told you that you have diabetes with high level of sugar in your blood , your dose of either afinor or insulin may need
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . if you take more afinitor than you should if you have taken more tablets than you have been told to , consult your doctor . if possible , your doctor may prescribe a lower dose of afincer . the usual starting dose is 5 mg once a week . your doctor will adjust the dose to 5 mg twice a day ( equivalent to 7 . 5 mg ). if you experience certain side effects , your dose may be reduced or you may stop
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and contact a doctor immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps if you notice any of these , tell your doctor straight away . other side effects of afincer include : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . donot open the blister . the tablets should be taken immediately after opening . do this to protect from moisture . do do not take this medicine if you notice any visible sign of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet contains 5 mg of Everolimus in each tablet . afincitor 10 mg tablet : each tablets contains 10 mg of of everlimus in one tablet . the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactos anhydrous . what afinitors looks like and contents of the pack afinit 2
what laventair ellipta is the active substance of lavent air ellipta . it contains two active substances called umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack laventive ellipta comes as a clear , colourless inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . this medicine works by tightening these muscles
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . warnings and measures talk to a doctor or nurse before using lavent air ellipta if you : have asthma , have heart problems , have high blood pressure , have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ), have epilepsy , thyroid gland problems ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . try to use it at the regular time of the day . do not use more than your doctor tells you to use . if you use more lavent air ellipta than you should if you have used more lavents than you have been told to use , contact your doctor immediately . symptoms of using too much laventAir ellipt
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties immediate breathing difficulty stop using Lav
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umechinium , 65 microgramms umecylidinia bromides and 22 microgramrams vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ' and magnesium stearate ). what laventAir ellipta looks like and contents of the pack laventear ellipta is an inhalation powder . the ellipt
tovya contains the active substance guselkumab , which is a monoclonal antibody . this medicine contains the type of protein called il - 23 . tremfya is used to treat psoriasis in adults with moderate to severe " plaque psor psor " which is an inflammatory condition that affects the skin and nails . it is used in adults to improve the condition on the skin , and to reduce symptoms such as scaling , shedding , flaking , itching , pain , and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and precaution talk to the doctor or nurse before using this medicine if you : have an infection or an infection with tuberculosis 36 have an infected or have symptoms of an infection you are at risk of infections ( see section " warnings and measures "). allergic reactions may occur following vaccination . if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 mg solution for injection ( 1 pre - filled syringe ) is for injection under the skin ( subcutaneous injection ). it may be given at a dose of 4 or 8 mg per injection . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect up in 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not give this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this if you have
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfia is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ), a condition where persistent or recurrentcteph cannot be adequately controlled by surgical treatment , exercise capacity and symptoms of the disease . chronic throembolicmonary hypertension is a condition in which blood pressure is too high , which affects the blood vessels of the
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if the patient has a heart problem . - have had a heart attack ( myocardial infarction ) in the last six months . - suffer from
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is supplied in a pouch or a pouch containing a spare pump containing your treprostinil . the pump is connected to the infusion line to reduce the risk of accidental overdose . the recommended dose is 1 mg , 2 . 5 mg , 5 mg and 10 mg per infusion . the infusion rate will be adjusted depending
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in10 people ): dizziness , light - headedness , fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with trepulmix vial . store it in the original package in order to protect from light . do this if it is accidentally frozen . do in exceptional circumstances if it are accidentally frozen and left at room temperature ( up to 30 ) for continuous subcutaneous infusion . if it has been frozen and kept at room temperatures
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treproprostineil ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristinila ( as water for injections ). each 2 . 5 ml vials of 2 . 25 ml contains treprosticinil ( sodium salt ) . each 10ml vialof 25 ml delivers treprostail ( so water for injection ). each 50 ml varmaceutical of treprosteinil and sodium salt . trempulmix 10
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thorinanes is used to : 1 prevent existing blood clots from forming . 2 prevent stopping blood clubs from forming in your blood . thorinne is used in adults to : - treat blood clumps in your bloodstream . - prevent blood cl clots in yourblood after an operation . - treat an acute illness called unstable angina . - protect your heart from the effects of a heart attack . - reduce the risk of blood clops forming in the context of your dialysis machine
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to heparrin , such as
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . it is used when the bleeding is not controlled or if there is any bleeding event that is not obvious . if you experience excessive bleeding , exceptional weakness , tiredness , paleness , dizziness , headache , or unexplained swelling , stop taking your medicine and contact your doctor immediately . if any of these apply to you , tell your doctor or nurse immediately . your doctor may decide to stop your medicine . if thorinANE is used in combination with other similar treatments , tell a doctor or hospital pharmacist immediately if you have : a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe label after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in 0 . 2 ml solution . each vial contains 2 , 000 mg of the active substances in enoxagarin sodium , and is for single use only . the other ingredients are water for injections . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , chlorobutyl rubber stopper and a blue polypropylene plunger rod . each carton contains
sensstend contains the active substances lidocaine and prilocaine . it belongs to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men , when the head of the penis is erect ( ejaculation ).
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using senststend : if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ) if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) if your doctor has prescribed you a medicine for anaemia ( methaemoglobinaemia
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per day ) in the morning and evening . the recommended starting dose is 1 spray ( 1 spray ) in each of the three areas of the head of the penis . the dose is 3 spray ( 24 sprays ) per day for 24 hours . the maximum recommended dose is 4 sprays per day . how to use use the spray container before using it . the pump mechanism is to be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may affects up to 1 in 100 people ) headache local irritation of the throat , irritation of or irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort in the pris itching in the place of the pen penis a high temperature . other side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer . donot puncture or burn the container . do this to avoid evaporation . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray container contains 50 ml of lidocane and 2 . 5 mg prlocaine ( see section 2 ). what senstends looks like and contents of the pack each spray container is a clear , colourless to light yellow cutaneous spray . each spraycontainer contains 6 . 5 ml of dispersion . each pack contains 20 sprays . each filter container contains 5 ml or 12 sprays ( see box ). what the pack looks like
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma that has not responded to complete resection in adults ( treatment including surgery or adjuvant therapy ) advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma ( if previous therapies have not worked or you are not able to take an autologous stem - cell transplant , or you have had a transplant ) advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the active substance in
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opdivor if you : - have problems with your heart ( a change in the rhythm or the heartbeat ) - have an abnormal heart rhythm - have any problems with any of your lungs ( breathing difficulties or cough ) - inflammation of the lungs ( pneumonitis or interstitial lung disease ) - diarrhoea - watery , loose or soft stools - have or have had any symptoms of inflammation of any intestines ( col
always take opdivo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much opdivoe to take the recommended dose of opdivone is 240 mg given as 2 tablets of 480 mg per day . your doctor will prescribe the most appropriate dose for you . the recommended starting dose is 4 tablets of opiono in combination with ipilimumab . the treatment will be started by a doctor who is experienced in the treatment of skin cancer . the dose of the recommended daily dose of opsdivo is 1 tablet of nivolumab per kilogram of your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at refrigerated temperature . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivulumab ( 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 24 mg of the active substances . the other ingredients are : nivodumab , sodium citrate dihydrate , sodium chloride ( see section 2 " opdivos contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what opdiv
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events (
do not take clopidogrel tad 30 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel tart . warnings and precautions take special care with clopidineogrelTad if any part of you is at risk of bleeding such : - if you develop a medicalcondition that puts you at risk for internal
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl to be given as one 75 - mg tablet once a day . at the start of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimu . tacforius is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacfortius is used to prevent rejection of the transplanted organ by your liver and kidneys , and to improve the functioning of your heart after any previous treatment you were taking after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , to any macrolide ( antibiotic ), to erythromycin , clarithromycin or josamycin . tacrolemus immediate release capsules are not suitable for use in children ( e . g ., tacni ). tacforia prolonged - release capsules should not be used in children and adolescents ( e. g . , tacrolyus ). tacrolamus immediate - release capsule should
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . always take the same tacrolimus medicine as your transplant patient . if you have been previously treated with a different tacroleus medicine , your doctor may prescribe this medicine alone . always check with the doctor or nurse if you think that the dose is too low or too low . this is to make sure that you have the right medicine to prevent the rejection of your transplanted organ . dose the dose depends on your
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and see your doctor immediately if you notice any of the following serious or severe effects : allergic and anaphylactic reactions ( benign or malignant tumours ) have been reported during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) agranulocytosis ( a severely lowered number of white blood cells ) haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) febrile neut
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . discard 1 capsule after opening the aluminium wrapping . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg prolonged - release hard capsules hard gelatin capsules : each capsule contains 1 mg tacrolamus ( as monohydrate ). tacforiu 3 mg prolonged release hard gelatin capsule : each capsules contains 3 mg tacrulimus (as monohydrate ) . tacfius 5 mg long - release capsules :each capsule contains 5 mg taclimus (" as monohydration "). capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell tacforis 0 . 0
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic
do not take clopidogrel zentiva - if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). - if your bleeding is not being controlled with other medicines . - if there is a risk of bleeding such as : - a stomach ulcer ; - bleeding within the brain ; - severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions take special care with clopidineogrel zinc : - if any other risk of taking cl
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the original carton in order to protect from light . clopidogrel zentiva may be used in aluminium blisters if the outer carton is damaged or shows signs of deterioration . do this if you notice any change in the appearance of the tablets . do away with the blister after you have taken them .
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopideogrelzentiva contain lactose ' and ' clopsidogl zentive contains hydrogenated castor oil ') tablet core : mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromell
yttriga is a radioactive medicine that is used in combination with another medicine to deliver tiny radiation doses . the treatment with yttrigra is a radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - - if your child is pregnant or planning to become pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before using yttrida - yttrada is a radioactive medicine . it is not to be used in combination with another medicinal product . - radiopharmaceuticals are not to transmit radioactivity . yttarga contains radioactive material . radioactive medicinal products are to be disposed of in accordance with local requirements . see section 2 under ' warnings and measures
the treatment will be initiated under the supervision of a physician experienced in the diagnosis and treatment of patients with specific diseases . the treatment will consist of a single dose and will be administered under the direction of a doctor experienced in diagnosis and appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises and local regulations . storage of radioactive substances will be in accordance with national regulation on radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( see section 3 " yttiga contains sodium "). what yttrada looks like and contents of the pack yttrida is a clear , colourless type i glass vial with a 10 ml clear , flat bottom and a silicon stopper with an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in patients who have not received prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide how much ciamBra you will receive . patients with lung cancer if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy , ciamba may be used as
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb . warnings and precautions talk to your doctor , pharmacist or nurse before using ciamBra . children and adolescents ciamba is not recommended for use in children and young children under 6 years of age . breast - feeding is not indicated during treatment with ciambre . if you have recently received or are about to receive a vaccine against yellow fever , talk to a doctor or nurse immediately before using this medicine . ciamra is not intended for use if you currently have or have
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out your dose based on this body surface area and will adjust the dose of treatment depending on your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamBra will be given by infusion into one of your veins . the infusion will last approximately 10 minutes . cimbra will be administered
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38ºc or greater sweating ( common ). infection may occur if you have less white blood cells than normal which is very common . infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ), have a fast heart rate , pain , redness , swelling or sores in your mouth ( uncommon ). allergic reaction ( common ): if you develop skin rash ( common , may affect up to 1 in 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with the reconstituted solution . do this if the infusion solution is not clear or colourless . if the solution is discoloured , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be
what ciambra contains the active substance is pemetrexed . ciamra 100 mg : each vial contains 100 mg of pemetreed ( as pemetrrexed disodium hemipentahydrate ). ciamba 500 mg : one vial delivers 500 mg of dispemetrexED ( as dispemetrhyded dis sodium hemipontahydrine ). after reconstitution , the solution contains 25 mg / ml of pemrexed without further dilution . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hydroxide
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which help fight certain infections in your blood . immunogam can be used to prevent increased levels of human hepatitis b immunoglubulins , immunoglofulin g ( gg ) in blood plasma of infected adults . immunoglogam is used to treat adults and children aged 6 months and older . immunomam is prepared by recombinant dna technology in patients with hepatitis b virus and haemodialysed patients . vaccination is a process in which a hepatitis birus carrier ( the immune system ) produces an immune
you must not be given immunogam : - if you have ever had an allergic reaction to human immunoglobulins or other blood products . - if your child has an iga deficiency . - in case of an allergic response to iga containing products . children and adolescents immunogamer is not recommended for use in children and teenagers under 18 years of age . immunogloglobulin can cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions may also include nausea ( arthralgia ), joint pain , low blood pressure and moderate low back pain . antibodies may be present in hepatitis b
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 mg given every 24 hours for 72 days . the recommended recommended dose is hepatitis b in haemodialysed patients ( 500 mg every 2 weeks ) administered by seroconversion . vaccination against patients with hepatitis b will be initiated by a hepatitis birus carrier . the hepatitis b antibody administration and seroconversions following vaccination courses
like all medicines , immunogam can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ) undesirable effects have been reported during clinical trials with immunogamer . the injection site is usually located in the muscle . common ( affect 1 to 1 users of 1 ,000 ) 7 common ( effects in less than 7
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunoam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogaman 1 mg / ml solution for injection contains 5 mg of human plasma protein ( pfizer ) in 96 ml solution . the other ingredients are polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunogamation .
remicade contains the active substance infliximab . infliximaab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ) and psoriasis . remicades is also used to reduce the number of inflammatory diseases in adults ,
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these active substances if you have tuberculosis ( tb ) if your doctor has told you that you have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take reminade with food . if any of this applies to you , tell your doctor before taking remicADE . if your dose of reminades has been reduced
the usual dose is : rheumatoid arthritis ( 3 mg for every kg of body weight ) psoriatic arthritis ( ankylosing spondylitis or bechterew ' s disease ) psoriasis , ulcerative colitis or crohn ' s diseases ( 5 mg for each kg of person body weight ). how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be given after you have received remicades over 1 year . you will be treated with remicad for 1
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and require treatment . if you experience any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction ( e . g . swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing ), skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild to severe and usually disappear within a few days . an allergic response may occur within
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicade may be used for infusion after 3 weeks when stored at 2 8 or 28 and for an additional 24 hours when stored below 25 ( see section 2 ). do away with remicades if you notice any particles in the solution after removal from the refrigerator . do away any unused medicine . this medicine is for
what remicade contains the active substance is infliximab . each vial contains 100 mg of infliximeab . after reconstitution , each ml contains 10 mg of infiximabe . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white and the solvent is clear . remicada is available in packs containing 1 , 2 , 3 , 4 ,
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson '. in parkinson ', disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan works by increasing the amount of dopamine that reaches the brain and helps to control movement .
do not take rasagiline mylan - if you are allergic to rasaga or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan belongs to a class of medicines called monoamine oxidase ( mao ) inhibitors . these are used to treat depression and parkinson ' s disease . rasafiline is also used in combination with medicinal and natural products ( e . g . st . john ' s wort , pethidine ).
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you should take rascagilrine mylan every day until your doctor tells you otherwise . if you take more rasgiline than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the rasvagiline Mylan carton . if a child swallows some tablets , tell your doctor . if more
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare rare ( may affect up to 1 in 1 , 000 people ) rare rare : very rare ( might affect up in 1 to 10 , 000 persons ) very common abnormalities movements ( dysphkinesias ) headache uncommon abdominal pain fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain (
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasagoiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggiline milan looks like and contents of the pack rasgiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the other side
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis . if your children have symptoms of infections such as fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . - tell your doctor if your or your child ' s child has ever had a serious heart condition . warnings and precautions allergic reaction allergic reactions are symptoms of an infection such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in adults and adolescents from 2 to 17 years old weighing 10 kg or more the usual dose is 30 mg once a day . hulio may be prescribed as 20 mg once daily . children from 2 - 17 years of age weighing 30 kg or less the usual dosage is 30mg once a daily . hulaio may also be prescribed for 40 mg once weekly . enthesitis - related arthritis in children from 6 to 17 months old
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor immediately if you notice any of the following side effects ( see section 4 ) since the last hulio injection : allergic reaction , including heart failure severe rash or hives swollen face , hands or feet trouble breathing or swallowing pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired , coughing . symptoms of nerve problems
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hul io 40 mg is a sterile solution for injection containing 40 mg of adalimab in 0 . 8 ml of solution . it is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 sterilised needle ,
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed a medicine for asthma or skin allergy ( intense inflammation in your nose ). - on other nsaids ( such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine is used in combination with topical steroids ( cortisone ). it may increase the risk of unwanted side effects . - if there have been bleeding problems ( such a severe form of haemophilia ) in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in your eye ( s ) once a day . the recommended starting dose is one single drop in the eye (s ) once daily for 2 weeks . the drops should be used within the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down with your thumb or fingers , close your
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufantanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . you should swallow the tablet whole with a drink of water . do not chew or crush the tablet . you can take this medication with or without food . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed whole with the disposable single -dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , especially slow and shallow breathing . if you get any of these side effects contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may affects up to 1 in every 10 people ) are inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy , increased
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do tell your pharmacist if you are taking medicines that are not being used . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid , magnesium stearate . what dzuvello looks like and contents of the pack dzuveyo is a white to off - white , round tablets , with " dz30 " debossed on one side and " 3 " debottled on the other side . it is
what erleada is erleADA is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it also works to treat sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment with testosterone - resistant prostate cancer . erlead blocks the action of androgens , which are involved in the growth and spread of the cancer . by blocking the action , androgens like apalutaamide stop prostate cancer cells from growing and dividing .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if if you think you may be pregnant or are planning to become pregnant ( see pregnancy , contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be given to children . this is because the medicine may cause seizures . tell your doctor if you take any medicines that could cause blood clots ( e . g . warfarin , acenocoumarol ). tell your physician if you have any heart or blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may prescribe a lower dose of 60 mg once daily depending on how you respond to erleada . taking this medicine take this leaflet and this leafle leaflet with you . it is best to take erleade by mouth . if you take more erlead than you should if you have taken more erlada than you have been told to , talk to a doctor or go to a hospital straight away . taking other medicines if you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( see section 2 ). serious side effects tell your doctor or pharmacist if you notice any of these side effects : fits ( seizure ) uncommon
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - coating of the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erlead looks
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for the scan ( a pet scan ) in adult men who have previously had treatment for prostate cancer . it may be used in combination with other tests to determine prostate specific antigen ( psa ) levels in the blood . depending on the type of the cancer , an axumin pet scan may be performed at a lower dose than usual . if the cancer has responded to the test , the doctor may decide to delay the scan . your doctor will decide how long you should be treated with axumin . this procedure is
do not use axumin if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . if you have kidney problems . if your doctor has told you to follow a low sodium diet . if this applies to you , tell your doctor before using this medicine . if axumin is given once a day for a day , the axumin scan will be repeated every 4 weeks . during the scan , you will be given your usual medicines to take at the latest 60 minutes before the axus injection . ur
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin must only be used in special controlled areas . this medicine will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . the quantity to be administered depends on the type of medicine being used . axul
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) the effects of the medicine were mild . common ( effects 1 to 100 users in 1 , 000 ) the side effects of axumin were mild to moderate and lasted for a few days . uncommon ( affects 1 to 10 users in 100 ): pain , rash , altered taste in the mouth , altered sense of smell . this radiopharmaceutical delivers low amounts of ionising radiation which is known to be associated with the growth of cancer and hereditary
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin must not be used after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as as as 16000 mg ). axumin 3200 mg : one vial delivers 3200mg of fluiclovin ( as 3200 μg ). - the other ingredients are 32000 mg sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks like and contents of the pack white to off - white powder for solution for injection , with a uniform colour . axum
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops are used to treat high pressure in the eye , an illness called glaucoma . the pressure in your eye increases , which can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some patients : if you develop too much acidity in your blood ( hyperchloraemic acidosis ). if this happens to you , tell your doctor . warnings and risks talk to the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes : 1 drop in each eye in the morning and 2 drops in the evening . do not use azopt in both of your eyes : if you have problems with your eyesight , talk to your doctor . azop is used for both eyes in 1 , 2 and 3 doses . how to use the azopt bottle : wash your hands before using it . remove the cap . the cap can be removed with a snap collar . hold the bottle with your thumb or finger ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects affecting up to1 in 100 people ) − effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red , swelling or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each bottle contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack
the active substance of forxiga , dapagliflozin , belongs to a group of medicines ( medicines ) taken by mouth to treat diabetes . it helps control the level of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ). forxigo is used to treat two types of diabetes : type 1 diabetes that occurs when your body does not produce any insulin . forxig is used for the type 1 type in which your body either does not make enough insulin or cannot effectively use the insulin it produces . diabetes occurs in people who are overweight or obese . type 2 diabetes : when
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor immediately if you experience any of any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is one tablet a day . this may be taken with or without food . the usual dose is one 10 mg tablet a week . your doctor may increase your dose to one 5 mg tablet once a week if you have a liver problem . your dose of your dose may be adjusted . your response to forxigo for type 1 diabetes is usually one 5 - mg tablet daily . swallow the tablet whole with a glass of water . this medicine swallow the tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are : angioedema ( very rare , may affect up to 1 in 10 , 000 people ): angioEDema ( swelling of the face , tongue or throat , difficulties swallowing , hives ) and breathing problems . diabetic ketoacidosis ( very common , may affects more than 1 in10 people ): type 2 diabetes ( rare , might affect up in 1 in 1 , 000 but very rare ). diabetic ketoatosis ( common ) may occur with increased levels of " ketone bodies " in your urine or
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone ( e1201 ), silicon dioxide ( e171 ), magnesium stearate ( e470b ). film - coating : polyvinyl alcohol ( partially
mifamurtide works by stopping the growth of certain bacteria which are resistant to the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults , adolescents and children between 2 and 30 years old . it is used when surgery is not possible to remove the tumour and chemotherapy has not been successful or has stopped the growth and spread of cancer cells . it also works by slowing down the rate at which cancer cells die and helping to bring them back .
do not take mepact if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you have ever taken medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). warnings and precautions talk to your doctor or pharmacist before taking mepactor if any of these applies to you : if you suffer from any of your following conditions : if your nsaids are severe , you should stop taking mepacact and seek medical help immediately : if this applies to your heart or blood vessels ; if
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide once a day . your doctor will tell you how many doses you need . the dose may be increased or decreased by your doctor . the maximum recommended dose is 12 mg once a week for 24 hours . your dose may need to be adjusted by your physician depending on your mepact treatments and on your chemotherapy schedule . your chemotherapy will be repeated every 36 hours
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepacting ( transient ) paracetamol . if you experience fever during treatment with mepACT , you should contact your doctor immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been experienced in patients who have received chemotherapy . tell your doctor or nurse immediately if you have continuing fever or chills . these may be signs of an infection ( see section 2 ). rash have been seen in patients taking mepacts . tell the doctor or hospital pharmacist if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the outer carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer cartons in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 hours . do this medicine if you notice any visible signs of deterioration .
what mepact contains the active substance is mifamurtide . one vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg of the active ingredient mifamate . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose ') 2 - dileoyls - sn - glyco - 5 - phosphate - l - serum monosodium salt ( see also section 2 " me
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness associated with rosacea ( redness of the face ). rosica is a severe form of high levels of blood flow in the facial skin that can lead to enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , thus reducing the excess blood flow and redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor , pharmacist or nurse before taking mirvasos : - if the medicine is injected under the skin ( for example , if you take certain medicines used to treat depression or parkinson ' s disease ) - if your doctor has prescribed monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , moclobemide ), tricyclic antidepressants ( e. g .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin ( usually on the face ) only . this medicine should only be applied to areas of your body that are larger than your body sizes . this should not be applied on your eyes , mouth , nose or vagina . if you use more mirvasoe than you should if you think you have used more miraso mirvasos is only applied to your face . the treatment should be started with a small amount of gel ( a pea - sized amount ). if your
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects that may be signs of worsening of rosacea are : worsening of the treatment with symptoms ( see section 2 ' warnings and precautions '). contact allergy . allergic reaction may include rash and rare angioedema . if you have a serious allergic reaction , including swelling mainly of the face , mouth or tongue , stop taking mirvaso and contact
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tube and pumps tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasoa contains methylparahsydroxy benzoate "), propylene Glycol . what mirvasos looks like and contents of the pack mirvas
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body against infection and cancer . bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in the lymph vessels of the body . the vegfs protein causes blood vessels to expand , thus increasing their ability to receive nutrients and oxygen . be vacizumaab slows tumour
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have any of these conditions , please tell your doctor before using this medicine . if any of them apply to you , tell your physician before using it . if your child is less than 6 months of age
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer . the usual dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , given once every 15 days . your doctor may adjust the dose depending on your general condition and on your size of tumour growing . how often mvasis is given your doctor or nurse will give you mvasia every 2 or 3 weeks . the number of infusions you receive will depend on how you respond to treatment . your dose of this medicine will be adjusted by your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects are usually mild to moderate . the side effects that may occur with mvai are usually caused by chemotherapy . if you notice any of these side effects after you have been given mvasis , tell your doctor immediately . allergic reactions tell your physician immediately if you have an allergic reaction , including : difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 and below 30 . do away
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active substances bevackizumb in 1. 4 ml and 16 ml of solutions contains 400 mg of of bevanacizumaab in 16 .5 ml . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack mvasic is
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children aged one month and older . tecartus can be used : alone or in combination with other medicines to treat refractory mantle cell lipoma ( mcl ) in adults . it works by interfering with the activity of your own white blood cells ( autologous anti - cd19 - transfduced cd3 + cells ). mantle cell cancer is a cancer that affects the immune system , especially the b - lymphocytes . mantle cell lysisoma is caused by b - cells entering the lymph tissue (
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - have a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy ) - have more than 3 white blood cell per kilogram of your body ( autologous use ) - are having tests or checks of your lungs , heart , kidney or blood pressure - have signs of infection or inflammation of your cancer ( graft - versus -
what tecartus is tecartuse contains your own white blood cells . your cells are collected by a specialised healthcare professional . your doctor or nurse will give you tecartuus through a catheter placed in your vein ( a procedure call leukapheresis ). your white blood cell are collected from your blood . tecartub is given to you by a doctor or a nurse . it is given as a single infusion into your blood ( intravenous infusion ) over 3 hours . it will take about 6 hours for your white cells to multiply . it may take about 2 to 3 weeks for your body to produce the desired
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention . the following serious side effects were reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness including confusion , memory loss , disturbances of brain function including
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . infusion bag : store in the original package in order to protect from light . diluted solution : chemical and physical in - use stability of liquid nitrogen has been demonstrated at a concentration of 150 micrograms / ml . this medicine contains genetically modified human blood cells and is essentially free of human - derived material . the product is stable for 36 hours
what tecartus contains the active substance is autologous anti - cd19 - transfduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 cd3 cells per 2 ml of solution . the other ingredients are : 106 anti - dcp3 + sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartucus is a clear , colourless to pale yellow solution for infusion . it is supplied in an infusion bag packed in a metal cassette .
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas , or gl
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi : - if any of these apply to you ( see section 4 ) - if there is blistering of the skin ( bullous pemphigoid ). janura is not recommended if you have a disease of the pancreatreas called pancreatitis . - if the risk of gallstones is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . you should continue taking this medicine until your doctor tells you otherwise . if your doctor advises you to stop taking this medication , you should talk to your doctor first . this medicine may be taken with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . if any of the above
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack
xultophy helps to control blood glucose in patients with type 2 diabetes mellitus . diabetes is when your body does not make enough insulin or the insulin that your body produces does not work as well as it should . this can lead to blood sugar . insulin degludec is a long - acting basal insulin . it helps to lower your blood sugar levels by helping your body make better use of liraglutide ( a type of glp - 1 ) and insulin during meals . xultophy is also used in combination with oral medicines for diabetes xultomet is also taken in combination to oral medicines ( for example
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you 39 are taking a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced to a minimum of one tablet daily . your doctor will monitor your blood sugar levels regularly while you are taking xulturo . if you have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition which occurs when you are treated with xultide ), you should
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for 8 weeks . you can take xupophy with or without food . xultide is supplied as a pre - filled dial - a - dose pen . the dose counter shows the dosecounter on the pen . you may take 1 tablet of insulin degludec and 0 . 088
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur with low blood glucose . if yourblood sugar level is too low , you may have hypoglycasemia ( see section 2 ). if this happens , stop taking xultophy and contact your doctor straight away . warnings and precautions talk to your doctor or pharmacist before taking xulophy : serious allergic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : do not store above 30 . store at 2 8 for a maximum of 21 days . do away with the blister after 21 days and discard the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime . each 3 ml ampoule contains 300 units of of insulin Degludeca 10 . 8 mg liraagluteide . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xultphil contains sodium ". what xultos looks like and contents of the pack
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ]- erbb1 and her2 [ erbb2 - erbb3 ]- these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working and kills cancer cells quickly . this is important as it prevents the growth and spread of cancer types . this product is used for the treatment of cancer of the lung ( non - small cell lung cancer ). giotrIF is used as your first treatment after prior chemotherapy treatment in squ
do not take giotrif - if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has low body weight ( less than 50 kg ) - warnings and precautions talk to your doctor or pharmacist before taking giotrantif - tell your doctor if your baby has kidney problems - if the child has side effects associated with lung inflammation ( interstitial lung disease ) - tell the doctor if you have liver problems - your doctor may need to change your dose or stop some liver tests while you are taking this medicine - if he / she has a severe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take this leaflet with you .
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotreif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea may be severe ; fluid loss common ( might affect up in 1 to 10 people ) low blood potassium ; worsening kidney function . if you experience diarrhoee after diarrhoeing , you should contact your doctor immediately . appropriate antidiarrhoeal treatment should be started at the same time as antidiarhoeal medicine . prior to receiving giotrine , you may
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotratif looks like and contents of the pack giotreif 20 mg film - coating tablets are white to off - white , round , biconvex ,
what orkambi is orkmbi contains two active substances called lumacaftor and ivacaftors . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found in the cystic fibre conductance regulator ( cftr ) in the lungs . the mutation causes an abnormal cftR protein that does not respond to lumacafor . how does ivacftor work ? lumacftors works by blocking the abnormal cFTr protein .
do not take orkambi if you are allergic to lumacaftor , ivacaft or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to change your dose of orkandemi . talk to a doctor if you suffer from liver or kidney disease . your doctor will monitor the dose of okambie . abnormal blood tests of the liver may be performed before orkami is given . tell your doctor if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 6 mg tablet once a day . your doctor may increase your dose to one 12 mg tablet twice a day depending on how you respond to orkambi . the recommended starting dose is 6 mg once a morning . your daily dose is 11 mg once in the morning . if you take more orkabi than you should if you accidentally take more than the recommended dosage , contact your doctor . how to take your doctor will tell you how many tablets to take
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate and are usually reversible . ivacaftor may be used to treat some of the following conditions . if you take orkandemi , you may experience serious side effects . some of these effects may be serious . if any of these occur , stop taking orkmbi and tell your doctor straight away . raised levels of liver enzymes in the blood may increase the risk of liver injury in patients with pre - existing severe liver disease . the worsening of liver function is also reported
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg film - coated tablets each tablet contains 100 mg lumacftor and 125 mg ivacftir . each tablet of orkmbi 200 mg film film - coating contains 200 mg lumiacaftor or 125 mg of ivacaptor . each tablets of orkyambi 100mg film - coat contains 125 mg lumicaftor ( as ivacafor ). each tabletof orkamberi 200mg film film film coating contains 125mg lumacafir ( as vial
what lynparza is lynparaz contains the active substance olaparib . olaparateib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors cause death by stopping cancer cells from producing an enzyme that helps repair dna . what lynparlee is used for lynparanza is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it is used when the cancer has
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given lynarza if any of these apply to you . if you have been given more than the recommended dose of lynparz , tell your doctor . if any part of the medicine gets serious , including low blood cell counts , your doctor may do testing to see if you still have some of the signs and symptoms of fever , infection , bruising , bleeding or more serious problems with the bone marrow
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily depending on your response to the doses of lynpalza capsules . tablets are not recommended . if you take more than a capsule of lynarza once a night , you may experience side effects . how to take take the tablet once a morning , at about the same time each day . take the tablets with a glass of water . do not chew or crush them . if
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . do away with any lynparza capsules that are accidentally frozen . lynparZA capsules can be stored at room temperature ( up to 30 ) for a maximum period of 3 days . any capsules that have been frozen should be discarded . the capsules should not be re - frozen
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparze is a white , opaque , hard capsule imprinted with " olaparaib 50 mg " and " astrazeneca logo on one side . lynparZA is available in packs containing 112 capsules or 448
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children aged 14 years and above . opioid overdose is a serious , life - threatening , and sometimes fatal , overdose . it is usually treated with breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an overdose . if you use more nyxid than you should if you accidentally use more than the recommended dose , contact your doctor or pharmacist immediately . if possible , use this nasal spray 2 to 3 times a day . you can use
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray . 1 . if symptoms occur , you should take the spray as soon as possible . do not rub the shoulders , ears , breastbone , sternum or inside the ear with a fingernail . 2 . if breathing is the chest moving , you can hear breathing sounds and breath on the cheek . overdose may occur if you have a response to touch or sounds , slow uneven breathing , breathing , snoring , gasping , gulping , blue or purple fing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms from opioid drugs . symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people . these symptoms are very common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . - the other ingredients are : ( in the powder : hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxax is available in a
what ovaleap is ovaleep contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is similar to a hormone produced naturally in the body ). how ovaleape works ovaleaps is used to : - stimulate the growth of the sacs ( follicles ) in the ovaries . - stimulate reproduction . - facilitate the production of sperm . - produce a immature egg cell . - start treatment with a medicine called " clomifene citrate ". - perform assisted reproductive technology procedures ( procedures that help you to become pregnant ) with a type called " l
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ), large ovaries ( sacs of fluids that carry blood from the ovaries to the womb ), ovarian cysts , unexplained vaginal bleeding if you know that you have cancer in your ovaries , womb or breasts if you suffer from any condition that makes normal pregnancy impossible ( ovarian failure , early menopause ), fibroid tumours of the womb , mal
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use this medication your doctor will give you this medicine by injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will usually receive this medicine within the first 7 days of your menstrual cycle . the medicine will be given to you once a day . if you do not respond to this medicine , you may receive a dose of 75 mg or 150 mg of this medicine once a week for 7 days . if your menstrual period is interrupted , you should not receive
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) type of reaction may occur after your ovaleop injection . tell your doctor immediately if you notice any of the following serious sideeffects in women lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian hyper
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it is stored for more than 3 days above 25 . once the cartridge has been removed from the refrigerator and has reached room temperature ( not above 30 ) it must either
what ovaleap contains the active substance is follitropin alfa . ovaleop 300 mg / 0 . 5 ml solution for injection : each cartridge contains 300 micrograms ( 22 microgram ) follitroin alf in 0 . 05 ml solution . ovalesap 450 mg / 1 . 5ml solution for injections : each cartridges contains 450 microgram ( 33 microgram) follitruin alfu in 0. 75 ml solution , each cartridge delivers 900 microgram of ( 23 microgram ). ovaleaf 900 mg / 2 . 5 mm solution for injecting : each carton contains 900 microg
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungus that causes infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). candidaemia ( a form of fun fungal illness caused by candida sp .) in non - neutropenic patients ( patients with abnormally low white blood cells count ) to treat candida spine . infections caused by the fungus flucon
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any other medicines , including herbal medicines . the medicines listed below are taken before voricoazole accord treatment : 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used against mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your dose may be increased by 400 mg once daily for 12 hours and 24 hours or by 200 mg once every 12 hours for 24 24 hours and by 200mg once every 100 hours . depending on how you respond to treatment your doctor may increase your dose to 300 mg once weekly . if
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate and of a short duration . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice ( changes in blood tests of liver function ), pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg of voronazole ( as besilate ). each tablet of vORiconazola accord 50 mg ( film - coated tablets ) contains 200 mg of the active ingredient voricleazole , each tablet is made up of : - voricoazoleaccord 200 mg : - the other ingredients are : - tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . - film coating : hyp
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older : you will be given a vaccine against ebla virus . this is a 2 - dose course of vaccinations . the other ingredients are : ebola virus disease : the zaire ebolavirus and filovirus . this vaccine contains the whole ebolairus . it does not give you ebola disease . warnings and precautions talk to your doctor or nurse before you are given mvabe a . vaccinations are given as follows : zabdeno vaccine 8 weeks later than m
your child will receive the vaccination course . the vaccine should not be given if your child has had a severe allergic reaction to any ingredient contained in the vaccine ( see section 6 . warnings and precautions talk to your child ' s doctor , pharmacist or nurse before your child receives mvabea . if your baby has had such a severe allergy reaction to an antibiotic called ' gentamicin ', the vaccine may not fully protect all children . if you have been given mvaguea if your newborn has had any kind of a severeergic reaction to , or has received any other vaccine injection , tell your child . if the child has
the dose of vaccine is given by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the first dose of vaccination will be given as zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be vaccinated as a single dose . the second dose is given as a separate dose . if your child is given more vaccine than he / she should primary vaccination first vaccination with zab deno red cap vial ( 0 . 5 ml ) second vaccination with mvabdenos yellow cap vials (
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where thejection is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where the needle is given generalised itching . the most common side effects are : common ( likely to affect up in 1 in 100 people
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolovirus nucleoprotein marburg in 0 . 7 ml of solution for injection . the other ingredients are : 108 micrograms of suspension derived from chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what mvaraa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronAT may also be used to : - treat a raised calcium level in your blood because of a tumour - it reduces the amount of calcium that is lost from your bones - this helps to stop your bones getting weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you : have a side effect called osteonecrosis of the jaw ( onj ) this can be a sign of bone damage in the jaw . your doctor may decide to reduce your dose of bondronatin if you suffer from cancer or related conditions . onj can occur even if you receive treatment for onj . stopping treatment for offj
this medicine is given to you by a doctor or nurse with experience in the treatment of cancer . it is given as an infusion into your vein . your doctor will do regular blood tests before you are given bondronat . the dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 - 4 weeks for an infusion in your vein , but this may be longer if you are over 15 years old . if there is a raised calcium level in your blood , it can be given as 1 or 2 injections over a period of 2 weeks . depending on your condition , your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 to 10 , 000 patients ): pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . do this medicine if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste
what bondronat contains - the active substance is ibandronic acid . each vial contains 2 mg ibandronat . - each ml of solution for infusion contains 2mg ibandor acid . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack bondronats is a clear , colourless solution . it is supplied in a glass vial containing 1 ml or 2 ml of clear , clear , opalescent , clear glass vials with a bromobutyl rubber stopper .
what zeposia is zeposeia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepOSia is used for zepoesia is a treatment for adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects multiple sclerosis . multiple sclerosis is a disease that attacks the immune system ( the body ' s defences ). symptoms include numbness , difficulty in walking and problems with vision and balance . relapsING remitting ms is a series of attacks on the nerve cells . the symptoms usually disappear for a few days or weeks
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack ( angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking zepoia if : you have irregular or abnormal heartbeats ( arrhythmia ) your heart is not working properly after treatment you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the right dose for you . your doctor may also check your heart rate and may also give you a ' treatment initiation pack ' with orange capsules . the first 4 days of treatment are given as 0 . 23 mg ozanimod . the next 1 - 4 days are given in a ' maintenance pack ' containing orange capsules containing 0 . 46 mg ozimod . your first 5 , 6 or 7 . if you take more zeposia than you should if
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure ) uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may affects more than one in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0. 46 mg : one capsule contains approximately 0 . 46 mg ozimod ( as hydration ). the other ingredients are : capsule contents : microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell : 0 . 03 mg : gelatin , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), black iron oxide
what temybric ellipta is temymbric elliptone contains two active substances called fluticasone furoate and umeclidinium bromide , which are taken together with vilanterol . fluticastone fureate belongs to a group of medicines called corticosteroids ( also called steroids ). umeleclidinnium bromeide and vilansterol belong to agroup of medicines known as bronchodilators . what temybarric elliptoe is used for temyebric elliptome is used to treat chronic obstructive pulmonary disease ( cop
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric elliptka - if your asthma is getting worse . this is because temymbric elliptha can cause asthma . - if any of these apply to you , tell your doctor . - tell your pharmacist if you have heart problems , high blood pressure , liver problems , tuberculosis ( tb ) of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric elliptka than you should if you have used more tembric ellipta than you have been told to use , contact your doctor immediately . symptoms of temybubric elliptoe may include
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) in copd is the most common side effect of temybric ellipta . symptoms of a lung infection may include fever and chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat caused by a fungal infection ( candidiasis ) in
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umeleclidinnium bromeide and 55 microgram ( 23 microgram ) of uleclidainium ( 22 microgram ), vilancerol and trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. how zininforoe works zin foro works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . tell your doctor if you : have kidney problems . have ever had seizures ( convulsions ). have ever suffered from any non - severe allergic reaction to otheriotics ( such such as
the recommended dose of zinforo is 600 mg given every 12 hours . the dose may be increased to 600 mg every 8 hours for some infections . the recommended dose is 8 mg every 12 weeks . it is given as a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . your doctor will decide how many treatments you need and how often you need to take . your dose may need to be adjusted . if you have some infections that have not responded to treatment , your doctor may decide to increase your dose to 5 mg every 14 days . if skin infections occur , your dose will be increased 5
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects . these symptoms may be a sign of urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . your doctor may decide to stop treatment with zinforo or to give you medicines to slow bowel movement . these may affect up to 1 in 10 people . your blood test will be performed to make sure that
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinofo looks like and contents of the pack zinfareo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin fizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic nerve pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer - if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabil pfiser . some patients taking pregaabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may increase
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregabialin pfeizer . take pregaboralin pferizer once in the morning and once inthe evening . for 59 patients , the usual starting dose is one tablet of pregibalin pfingizer once a morning in
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregaboralin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregibalin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hydroxide ( e433 ).
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this is a stimulant in the body , and is very important for the functioning of the brain in parkinson ' s disease . xadago helps to control parkinson ', a condition characterised by sudden swings in movement , not being able to move or difficulties moving . xademago is used in adults , adolescents and children aged one month and older . the medicine is used together with levodopa ( other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is taking any of any of these : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , and tranylcypromine . these are all used in treatment of parkinson ' s disease or depression . - if the child is being treated with pethidine , a strong pain killer . warnings and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg twice a day ( one 100 mg tablet ) taken by mouth once a day . your doctor may prescribe a lower dose if you have moderately reduced liver function . the usual dose is 50mg twice a week . take xadadago at the same time each day . swallow the tablet whole with a glass of water . you can take xadeago with or without food . if you take more xadagon than you should if you accidentally take too many tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : hypertensive crisis ( very high blood pressure that may lead to collapse ) - neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia , increase level of enzyme creatine kinase in your blood ) - serotonin syndrome ( e . g . confusion , hypertension , muscle stiffness , hallucinations , hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually disappear
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadagon looks like and contents of the pack xadagus 50 mg film - coated tablets of 7 mm diameter with metallic gloss are marked with ' 50 ' on one
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in your blood . prostate cancer is a type of disease where treatment with hormone therapy is not possible . a treatment that lowers testosterone ( androgen deprivation therapy ) is not available . ztiga is used in combination with another medicine , prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the medicine properly and which causes fluid retention in yourblood
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytig if you have severe liver damage or prostate cancer . this medicine should not be taken with this medicine . tell your doctor if any of these apply to you . if you take more zytigo than you should if you accidentally take too many tablets of this medication , tell your physician immediately . tell the doctor if you : have liver problems such as high blood pressure
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this leaflet and this medicine with food . swallow the tablets whole with a glass of water . do not chew or crush the tablets . take this tablet by mouth . if you take more zytiga than you should if you accidentally take more than the recommended dosage of zytige , contact your doctor . if possible take the tablets with food , preferably at the same time each day . if necessary , take them at least 2 hours
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor may check your potassium more frequently . other side effects include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet ( see section 2 ' warnings and precautions '). - low blood potassium ( seen in liver function test ). - high blood pressure . - urinary tract infection . - diarrhoea
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round , 9 . 5 mm in diameter . the tablets are provided
hefiya contains the active substance adalimumab , which is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedial crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab works by blocking the activity of a protein called tumour necrosis factor ( tnfα ), which is involved in the inflammatory diseases and in causing the inflammation
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . warnings and precautions talk to your doctor or pharmacist before taking hefiYA if your / your child : has a history of unusual infections or a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . has moderate or severe heart failure . has a serious heart condition . allergic reaction if your ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . your child ' s doctor will tell you the dose to take . the dose may be increased or decreased by your child . the usual dose is 20 mg once a week . your children ' s physician will tell them the dose that is right for them . the doctor may also prescribe a 20 mg tablet or a 20mg tablet once daily . polyarticular juvenile idiopathic arthritis age and body
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 ) since the last hefiya injection : allergic reaction ( e . g . heart failure ) severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . tell a doctor straightaway if you have any of these signs and symptoms of infection such as fever , feeling sick , wounds , dental
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe must be used within 14 days or discarded
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this cell , it stops the cell from growing and dividing . what ritemva is used for ritemvi is used to treat adults with a ) non - hodgkin ' s lymphoma . this is an advanced form of a disease of the lymph tissue that affects the immune system . it affects
do not take ritemvia if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ( see section " warnings and precautions "). warnings and risks talk to your doctor before taking ritemvi if you : have ever
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . your doctor may decide to reduce your dose or stop you using this medicine if you experience any side effects . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritemvi administration are given to you by your doctor . ritemvir may be given with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . if you have non - hodgkin ' s lymphoma if you are
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number of plate
what ritemvia contains the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of concentrate contents contains 10 mg of the active ingredient in ritueimab ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemv looks like and contents of the pack ritemvi is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitabe teva is used in the treatment of colon , rectal , gastric , or breast cancers . capecabine cheva is prescribed to be used in adults who have advanced stage of colon cancer after complete removal of the tum
do not take capecitabine teva - if you are allergic to capecitabiline or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may have an allergy to this medicine . - if any of these apply to you , tell your doctor before taking capecitafine teeva . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - if : you have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) - if the patient is pregnant - if he / she has low levels of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva depends on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once daily . this is equivalent to a daily dose of body weight of 64 kg and height of 1 . 64 m² . a body surface effect
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements . if you get any diarrhoee at night , vomiting , vomit , nausea and lose your appetite . stomatitis : if your doctor thinks you may have pain , redness , swelling or sores in your mouth and / or throat , especially in the hand or foot . skin - reaction : if pain , swelling , red
what capecitabine teva contains the active substance is capecitabiline . capecitabe teva 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . the other ingredients are : capecitamide teva 500 mg film film - coat contains 500 mg capecabine . tablet coating : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hyproellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e 172 ). what
silodosin recordati contains the active substance silodosino . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . it also helps to reduce your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water and a feeling of not completely emptying the bladder .
do not use silodosin recordati if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi if you have undergone eye surgery to reduce cloudiness of the lens ( cataract surgery ) in one eye 26 silodosiin recordat may be used alone or in combination with medicine to reduce a loss of muscle tone in the iris ( the coloured part of the eye ). during a surgery , appropriate precautions should be taken , including when using medicine and surgical techniques .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule once a day , taken at about the same time each day . you should take silodosein recordat for at least 8 hours every day . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . taking this purpose silodosiin recordatin is for oral use . swallow the capsule whole with a glass of water . do not open or crush the capsule . if it is more than
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect of silodosin recordati is dizziness . dizziness may also occur with difficulty in swallowing , feeling shaky or weak or dizzy . the symptoms can be described as dizziness and fainting . if you experience any of these , stop taking silodosiin recordat and seek medical advice straight away . complications following a cataract surgery ( eye surgery ), cloudiness of the
what silodosin recordati contains silodosein recordat 8 mg : the active substance is silodofin . each capsule contains 8 mg silodino . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosesin recordatin 4 mg : each capsule contain 4 mg siliodosin . the ingredients are : mannola , magnesium unstearate, sodium lurilsulfATE , gelatin, titanium dioxide , yellow iron oxide ( e172 ). what silodosiin recordi looks like and contents of
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzialmonic is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months have passed since you last took a tablet . - if your doctor thinks you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking kinzdalmono ( see pregnancy section ). - tell your doctor if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . - tell the doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed with some water . you can take kinzalmono with or without food . try not to take more tablets than your doctor tells you to . if you take more kinzdalmono than you should if you have accidentally taken too many tablets , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzhalmono is 40 mg once
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( blood poisoning ) is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) cardiovascular events uncommon side effects : may affect upto 1 in 100 people : urinary tract
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . once your medicine has been taken out of your refrigerator , it must be used within one hour . do this by gently squeezing your kinzalmono tablet out of its blister . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round tablets with " pfizer " debossed on one side and " nvr " debottled on the other side . kinzaloo is available in blister packs of 14 , 28 , 56 and
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology . the active substance is lonoctocog alfa . afstylfa is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor vii is involved in blood clotting and is necessary for blood to clot . an increased tendency to bleed is due to lack of factor v ii in patients with hahemophilia b . afsta helps blood to form its own clot .
do not use afstyla if you have had an allergic reaction to afstylea or any of the other ingredients of afstyra ( listed in section 6 ). if you are allergic to hamster proteins . warnings and precautions 46 talk to your doctor , pharmacist or nurse before using afstrya . check the batch number and the date of administration in your treatment diary . afstlinga may cause allergic ( hypersensitivity ) reactions . talk to a doctor , nurse or pharmacist before using this medicine . allergic reactions are symptoms of allergic reactions . allergic symptoms may include hives , generalised skin rash ,
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the dose of afstyla you receive will depend on the severity of treatment , the severity and location of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) must be dissolved before use in order to avoid aseptic conditions . afstila must not be mixed with other medicines or solvents . see section 6 .
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness ( anaphylaxis ), bleeding . in patients receiving factor viii medicines , inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). however , patients who have received previous treatment with factor v iii ( more or less than 150 days of treatment ), the risk is uncommon ( less
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . do away with the vial if it is not clear . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw
what afstyla contains the active substance is loroctocog alfa . each vial contains 250 iu ( 2 . 5 mg ) of lonoctocag alfa ( as 100 iu ). after reconstitution , 2 .5 mg contains 200 iu lonoectocog aluminium ( as 1000 iu ) and after reconstallion , 2. 5 mg contains 400 iu of loroectocag aluminium (as 1500 iu). after reconitution , 5 mg contain 300 iu / lonoCTocog alpha ( as 2000 iu ), after reconning , 5mg
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombinant agent of dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidlytrap dabigATran . what it is usedfor ? prax binds to pradxa in patients who are undergoing emergency surgery or need urgent procedures to stop uncontrolled bleeding .
do not use praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( haf ). if the substance sorbitol ( a substance present in this medicine ) is present in the blood , it is unlikely that this medicine will cause serious adverse reactions . warnings and precautions talk to your doctor or pharmacist before using prax bind . this medicine contains dabigatran which is used in combination with other medicines to prevent blood clots . dabigATran is taken by mouth to prevent the
the recommended dose is one 5 mg film - coated tablet ( equivalent to 2 . 5 mg dabigatran ). this medicine is given to you once a day . your doctor will decide how much film - coating tablet you need . the recommended dose for adults is one film - coloured tablet ( approximately 5 mg ) once a week . this medicine will be given into a vein . your dose of this medicine may be adjusted , or your treatment may be delayed depending on blood clot formation . your daily dose of dabigratran will be reduced by 24 hours after you have been given this medicine . if you have any further questions on the
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temmedac is first given together with radiotherapy ( concomitant phase of treatment ) and then monotherapy phase oftreatment ( phase 3 ). - in children with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temormac is given in combination with standard treatment .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . - if certain types of blood cells are severely reduced ( myelosuppression ) - your white blood cell count and platelet count are severely decreased . these blood cells help fighting infection by preventing proper blood clotting
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ) that are similar to temomedic ( see section " other medicines and temomedAC "). in particular , please tell your doctor if you experience nausea or vomiting . if you currently have newly - diagnosed glioblastoma
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache , stop temomedac treatment and seek medical help immediately . there may be a reduction in certain kinds of blood cells . this can cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can lead to anaemia (' apl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains the active substance is temozolomide . temomedacon 5 mg : each capsule contains 5 mg temozolsomide ( as temomedab ). temomedax 20 mg : one capsule contains 20 mg tem ozolomides ( as mesomedab . temmedac 100 mg : two capsules contain 100 mg temzolomine ( as besilate ). temmedax 140 mg : three capsules contain 140 mg temazolomid ( as esilate . temarthac 180 mg : four capsules contain 180 mg temizolomile ( as desilate). the
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis for adult women . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by blocking the blood vessels in your penis . this helps to keep the blood in your erect penis working smoothly . this makes erectile function more effective . ceralis is used to treat adult men who have erectile disease . cival
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . these medicines may increase the amount of nitrate in your blood . - if any of these apply to you : - if the patient has serious heart disease - if he
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack . if necessary , show the doctor the pack of tablets . if a child swallows some tablets , tell
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain when taking nitrates ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . if this happens , stop taking cialis and seek medical help straight away . if you have an erection that lasts longer than 4 hours , contact your doctor immediately . sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects very common ( may affect more than 1 in 10 people ) uncommon ( may affects
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e 172 ),
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . enyglide is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood blood sugar should be controlled when you are treated with eny glid or metformin . diabetes is also a condition in which
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your dose is too high . if any combination of eny glid or gemfibrrozile ( a medication used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg once daily . your doctor may increase your dose to 4 mg once every day . your daily dose may be increased to 30 mg twice a day ( every 16 days ). if you take more enylid than you should if you accidentally take too many enygrelid tablets , or if someone
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . hypocaemic unconsciousness may lead to coma . allergy allergy ( rare , may affect 1 in every 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects include : common ( may effect up to1 in 10
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet and red iron oxide (< e172 ). only in 2 mg tablet . what eny glid looks like and contents of the pack eny
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azac citidine mylon is used for azaccitidine myla is used to treat adults . what it is used in adults azacacitine mylan has been prescribed for you by your doctor . azacituidine mygal is used after a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult patients with chronic myelomonocytic leukaemia ( cmml ). it can also be used in
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine mylan : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition that makes you prone to heart attack . - your doctor may ask you
before starting azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor may increase your dose of this medicine depending on your height and weight . azaccitidine myl is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) by subcutaneous injection ( sub - subcutting ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( e . g . abdominal bloating and easy bruising ), which may be symptoms of liver failure , swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever may be a sign of an infection with low levels of white blood cells
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . once the suspension has been dissolved , it should be used immediately . the suspension should be stored at room temperature ( up to 1 ). the azacnitidine mylon suspension must be used in combination with water for injections . thesuspension must be stored in a refrigerator ( 2 8 ). the zacitine mylan suspension must not be frozen .
what azacitidine mylan contains - the active substance is azacitonidine . one vial of powder contains 100 mg azacituidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg azaitidine . - the other ingredient is mannitol ( e421 ). what azaccitidine myl looks like and contents of the pack azacididine mylon is a white powder for suspension supplied in a glass vial containing 100 mg of azacito . pack sizes of 1 and 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue , which is produced naturally in the eye . timolole is a beta blocker which reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness , difficulty in breathing , long - standing cough or breathing problems . - tell your doctor if the patient has severe hay fever or a slow heartbeat . - warnings and precautions talk to your doctor before taking duotra : - if child has heart failure ( a disorder
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in each eye twice a day . do not use duotrav in both eyes . use duetrav in the affected eyes only . how to use duofrav is for oral use . the recommended amount of eye drops is 1 drop in the morning , 2 drops in the evening , 3 drops in in the afternoon and 4 drops in a bottle . 1 step before using : wash your hands . remove the bottle from the bottle . hold the bottle , pointing
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle to help protect your eyes . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects on the eye eye redness . common side effect ( may effect up to 1 in every 10 people )) effects on how the eye surface inflammation ( surface damage ) may include eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include : eye irritation , burning or stinging . uncommon side effects these may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg of travostrost and 5 mg of timolole ( as timololine maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg . - the ingredients are : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . acidity levels may be increased when duotra is diluted .
nplate ' s active ingredient is romiplostim . it is a protein used to treat low platelet counts in patients with a condition called immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important for protecting the blood from blood clots . very low platelets counts can cause bruising and serious bleeding ( see section 1 ) in patients who have had their spleen removed . in patients suffering from chronic itp who have previously received corticosteroids or immunoglobulins . nplate
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking nplate : if you have a low blood platelet count ( thrombocytopenia ) if you take n plate . your doctor may need to adjust your dose . if your platelet counts are too low . if you suffer from blood clots . if blood clotting is not properly controlled . if any of these apply to you , tell your doctor
nplate is used in adults and adolescents from 1 to 17 years of age . your doctor will decide how much nplate you need and how often you need to take nplate . nplate is given as an injection under the skin ( subcutaneous ) ( see section 1 ). how nplate works nplate will be injected slowly over a period of time . your platelet counts will be checked regularly . your blood will be taken regularly to check that your platelets are working properly . your dose will be adjusted depending on how well your blood is clotting . the dose of nplate that you receive will depend on : your body
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in10 people ): bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing , blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indigestion
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romiplustim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial provides 125 mg of romiplOSTim . - nplate 250 mg powder : each single dose vials contains 375 mg romclostim ( as 25 mg / ml ). each single single -dose vial delivers 250 mg of Romiplostime in a deliveredable amountof 0 . 5 ml solution , each single treatment vial
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanOR breez inhaler is used for this medicine is used to help to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine prevents tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on cop
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - tell your doctor if you have kidney problems - tell the doctor if your doctor has told you that you have an eye problem called narrow - angle glaucoma - tell his or her doctor if this applies to you - tell them that you are having difficulty passing urine . treatment with tovannor breezer should be stopped immediately if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose is one inhalation once a day . this medicine is for inhalation use . however , if you use more tovanOR breez inhaler than you should if you have used more to this medicine than you have been told to , contact your doctor . how to use this medicinal product is provided as an inhaler and capsules ( in blisters ) containing the medicine ( inhalation powder ). the capsules are provided in separate cartons .
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopirroniumbromide and 50 microgramms glycopyronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgramrams glycopYRronium per inhalation dose . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microsp
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia or bipolar disorder . these are diseases characterised by symptoms ( such as schizophrenia ) hearing , seeing or sensing things which are not there , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious or tense . adasve can also be used to help you remember to
do not take adasuve if you are allergic to loxapine or any of the other ingredients of amoxaprine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath . these may occur 25 in adults . neuroleptic malignant syndrome ( nms )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( taken in 2 to 4 . 5 hours ). you should take adasuve every day until your condition improves . you should continue to take adasve until your doctor tells you otherwise . you can take adamsve with or without food . you may take adamasve with food or drink . it is best to take it with a meal or just after a meal . you must take adamasuve with a glass of water or just before
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects : any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating , or affecting your airways ( asthma or copd ). light - headedness or fainting . these may be signs that your blood pressure is not being controlled as well as it should . worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with adasuves if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . when adasuves delivers 4 . 5 mg loxapeine , the active ingredient is released in the form of micrograms . what adasuva looks like and contents of the pack adasuvey 4 .5 mg is a white to off - white plastic inhaler , containing loxpine . the pack is packed in a sealed foil pouch . adasuved 4 . 4 . 0 mg is available in packs containing 1 or 5 inhalers . not all pack sizes
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent which belongs to a group of medicines called cytokines . what azaccitidine betafarm is used for azaciticidine betaparm is given to adults . azacituidine betagarm is prepared as a stem cell transplantation for the treatment of : higher - risk myelodysplastic syndromes ( mds ) chronic myelomonocytic leukaemia ( cmml ) acute myeloid leukaemic ( aml ). aml is a group or combination of diseases
do not take azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition that makes you prone to heart attack or lung disease . blood
before starting azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor may increase your dose of this medicine depending on your height and weight . your dose will be adjusted by your doctor . azaccitidine betabarm will be given every 3 weeks during this " treatment cycle " ( cycle 4 , 6 ). this medicine will be injected under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which may be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which could be symptoms or signs of kidney failure ). a fever ( which might be a sign of an infection caused by low levels of white blood cells ). chest
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . any unused azaccitidine betabarm must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be administered within 45 minutes of preparation . the azacituidine betafarm suspension must not be mixed with water for injections . the mixture must be dissolved within 8 hours . the solution must be used within 8 minutes . the zacitine betapham suspension must also be mixed together with water and injections . if not
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azacinidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). what azacituidine betabarm looks like and contents of the pack azaciticidine betafarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacite .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucosophceramide , it stops the enzyme from working in your affected organs . your doctor will test for this before you start taking this medicine . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . warnings and
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 or moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor before taking cerdelg . cerdelgas should not be used in patients with medicines known to be a poor metabol
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of metaboliser twice a day . the amount of metabolizer that your body produces is based on your body ' s weight . the usual dose is two tablets of 80 mg twice a morning , one tablet in the evening and one tablet at the evening . the maximum recommended dose for adults is one 84 mg tablet once a day , with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you take more cerdelga
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgas
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to : prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). to reduce the amount of calcium in the blood in adult people where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir - if you are allergic ( hypersensitive ) to zoledor acid , another bisphosphonate ( the group of substances to which zoledoral acid belongs ) or any of the other ingredients of zoledicle acid hospire ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using zoledric acid hospiar : - if any of these apply to you , tell your doctor before using it .
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ). ' iv ' administration is recommended in order to reduce dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may decide to lower the dose depending on your kidney problem . how often zoledron acid hospir is given your doctor will decide how often you should be given it . if your doctor determines that zoledic acid hospiar is inappropriate for you , your dose may be reduced . if there are any
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain blood tests ) low level of calcium in the blood uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness , or loosening of a tooth . these could be signs of bone damage in the jaw ( osteone
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledor acid contains 4 mg zoledorus acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledico acid hospirica looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains rolapitant which is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . this type of chemotherapy destroys nerve cells in the brain , causing vomiting . people who are sick ( sick ) do not respond normally to rolapit . these nerve cells help to control nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has prescribed varubry for you . if you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). if you think this medicine is not suitable for you , talk to your doctor or pharmacist . warnings and risks 27 if you suffer from severe liver or kidney problems . if your dose of certain medicines ( e . g . rifampicin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . you may take it with or just after food . it is best to take varubsy at least 2 hours before your chemotherapy cycle . if you take more varubys than you should if you have taken more tablets than you were told to , contact your doctor straight away . if possible , show them the pack . if sickness occurs ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , and he or she may decide to give you appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache , constipation , feeling tired uncommon ( may
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapit . - the other ingredients are lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubry is a
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : - indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycoprronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this makes it easier for air to get in and out of the lungs and makes it less likely that you will have to go to the hospital . mometsone fruate belongs to a medicine group called corticosteroids and
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems if you get an irregular or fast heartbeat if you suffer from thyroid gland problems if your family has diabetes , high blood sugar , seizures if you drink alcohol if you smoke if you know that you have severe kidney problems if any of these
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler twice a day . the medicine should be inhaled once a day with food . use enerzair breezhaler every day , at the same time of the day . this will help you to remember to use it . if your asthma is not controlled well enough , your symptoms may get worse . use the same dose every day . do not change the dose of enerz air breez inhaler without talking to your doctor first . how to use enerzeair bree
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching , hives . allergic reaction other side effects other side side effects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness , wheezing
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate ( asacetate ), 63 microgram of glycopreyronium bromides , 50 microgram ( glycopyronium ) and 160 microgram( mometsone firoate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram / gram of indiacaterol , 58 microgram gly
clopidogrel acino pharma gmbh contains the active ingredient clopidodogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmá gmbhs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopridogrel or any of the other ingredients of clopidineogrel macrogh . if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopidiogrelacino pharmá gmbhl . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopridogrel aclara gmbhl per day to be taken orally with or without food . you can take clclopidigrel acina pharma h for as long as your prescription continues to provide you with adequate protection from bleeding . if you take more clopidoogrelacino pharmá gmb h than you should if you accidentally take too many tablets , contact
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects up to 1 user of 10 , 000 ). very rare ( affect less than1 user in 10 ,000 ). not known ( frequency cannot be estimated from the available data ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogl acino pharma gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopidineogrelacino pharmá gmb h looks like and contents of the pack clopidiogrel acc
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are taking medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and lamivudine ( ( a nucleosides analogue reverse transcriptases inhibitor ( rrti ). the other active substances in delstrigo are tenofovir disoproxil ( a neoside analogue reverse transcriptionase inhibitor , nrti ), and tenofovair disaproxil . delstriga
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if your doctor has told you that you are taking any of : - the following medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ) - st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . - products containing mitotane ( a
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for the treatment of hiv infection . the usual dose is 1 tablet a night . your doctor may prescribe you certain medicines ( such as doravirine ) to help you stay on the right medicines . taking this medicine swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . taking the tablet before you take delstigo , you should take delstromigo for
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts 45 trouble concentrating memory
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar . a coating material : carnauba wax e903 , hyproellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression . spravato is used to treat the symptoms of depression in adults , adolescents and children aged one month and older . these include feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and a feeling of being slowed down . sprevato is usually taken with another antidepressant . it is important that you continue taking spravatos for at least 2 months after you have stopped taking it . if you have any further questions on the use of antidepressant medicines
do not take spravato if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). if you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). if recently had a heart attack . within 6 weeks of taking spravat . a temporary increase in blood pressure . this can lead to serious complications in these conditions . if any of these apply to you , tell your doctor before taking spraveato . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravatos nasal spray is for oral use . the nasal spray device is for use in adults . use in children and adolescents 1 year of age and older . use within 2 years of the last dose . use 3 nasal spray devices . use one nasal spraydevice once a day for 4 days . use spravata once a week for 2 weeks . use this medicinal product every day at the same time of the day . if you use more spravat than you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected , feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation vertigo vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy , euphoria feeling agitated feeling anxious , feeling anxious in the eyes , ears or sense of touch are impaired or mimicked irritable panic attacks change in perception 37 feeling , hearing ,
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravatos looks like and contents of the pack spravat is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available as a single - use nasal spray unit . spraveato is available in packs containing 1 , 2 , 3 or 6 nasal spray devices
zerboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer is caused by a change ( mutation ) in a gene responsible for the growth of melanoma . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor or nurse before using zelberaf . allergic reactions if you experience allergic reactions to zeloraf , tell the doctor or hospital pharmacist before using it . if you have any symptoms of an allergic reaction , such as swelling ofthe face , lip or tongue ), difficulty breathing or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for up to 8 weeks . your doctor may increase your dose to 4 mg twice a day if you experience side effects . your treatment with zelboraf may be stopped if you suffer from vomiting . take zelbaf with food . zelbaraf should be taken on an empty stomach . swallow the tablets whole with a glass of water . do not chew or crush the tablets . if you take more zelberaf than you should if you accidentally
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelbaf and tell your doctor immediately if you notice any of the following : radiation treatment tell your nuclear medicine doctor immediately after zelberaf treatment if you get any of these signs : radiation affecting the skin , esophagus , bladder , liver , rectum , and lungs tell your radiation doctor immediately : if you have any of any of those signs : skin rash , blistering , peeling or discoloration of the
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any particles in the solution or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). - the other ingredients are hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zel
duoplavin contains two separate medicines : clopidogrel and acetylsalicylic acid ( asa ). these belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead
do not take duoplavin - if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) - if your child is allergic to other products called non - steroidal anti - inflammatory products - if the child has painful and / or inflammatory conditions of muscles or joints - if he / she has a medical condition ( such as asthma , nasal discharge , runny nose , polyps or any type of growth in the nose ) - have a medicalcondition that is currently causing bleeding such as a stomach ulcer or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , tell your doctor immediately . if possible , take the tablet with you and this leaflet with you . you may need to go to the nearest hospital emergency department to reduce the risk
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances : clopidogrel , acetylsalicylic acid (asa ) 75 mg : clapidogel ( hydrogen sulphate ) 75mg : acetylSalicylic acids , mannitol , macrogol 6000 microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '), stearic acid and colloidal anhydrous silica
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to the group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have been previously treated for eye conditions such as glaucoma , ocular hypertension ( high pressure in one or both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you cannot take certain antidepressants if you suddenly stop taking any antidepressant medicines if you suffer from severe kidney problems if you develop too much acidity in your blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid contact with the drops in your eyes . wash your hands thoroughly after using simbrinitza ( see section 1 , " how to use simbritza "). remove the cap and snap collar . hold the medicine with your fingers . tilt the bottle back . pull down the eyelid with a clean finger and squeeze until there is a ' pocket ' between the eyelids and the eye . the drop will go in here ( see picture 1
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor immediately if you have a reaction to the medicine ( frequency not known ). signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body or eyes trouble breathing , chest pain , or irregular heart beat . tell your heart doctor immediately extreme tiredness or dizziness . the other side effects that may occur with simbrinza are : other medicines containing brinzolamide and brimonidine . common side effects ( may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , use within 4 weeks to prevent infections . do use a new bottle if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brinza and 2 mg of bimonidine titrate equivalent to 1 . 3 mg of Brimonidine . - the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water , hydrochic acid
what filgrastim ratiopharm is filgrastaim ratisopharm contains the active substance filgrustim . filgrasteim is a protein produced by biotechnology in bacteria called escherichia coli . it is similar to a natural protein produced in the body called granulocyte - colony stimulating factor ( g - csf ). filgrasterim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgnastim helps to increase the number of white blood cells in your body . filgrim
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgraspim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitopharm : - if your child has a cough , fever or difficulty breathing . these may be signs of a pulmonary disorder . tell your doctor if your baby has any of these side effects . sickle cell disease 57 if your newborn gets left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a
how much filgrastim ratiopharm is given the amount of filgrastaim ratisopharm you will receive will depend on your condition and on how well you respond to filgrasim ratim raticoopharm . the amount you will be given will depend upon your condition . your doctor will tell you exactly how many tablets of fil grastim ratiopharm to give to you . filgrasteim ratiotopharm treatment will be started by your doctor or nurse . the recommended dose of filbrastim ratsiopham given to you before chemotherapy is 0 . 5 mg per kil
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will do regular blood tests before you are given filbrastim ratiopharm to check the number of neutrophils ( a type of white blood cells ) in your blood . your blood will be tested before and during treatment . other medicines and filgrasteim ratisopharm tell your doctor or pharmacist if you are taking , have
filgrastim ratiopharm will be stored by the health professionals at the hospital or clinic . the storage details are as follows : keep out of the reach and sight of children . do not use filgrastime ratiophilearm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do do not take filgrasteim ratisopharm if you notice that the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrateim . filgraspim ratiotopharm 30 mg : each pre - filled syringe contains 0 . 5 ml of filGrastim in 0 . 0 ml solution . filgnastim ratiopharm 48 mg : one pre -filled syringe containing 48 mg of filmgrastrim in 0. 8 ml solution for injection . - the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , polysorb
what riluzole zentiva is riluxole zenta contains rilusole which belongs to a group of substances called cytokines , which are involved in the nervous system . what rilizole zintiva is used for rilukole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ), a form of motor neurone disease in which the nerve cells that control muscles develop weakness , muscle waste and paralysis . this causes the destruction of nerve cells . motor neurONE disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . ril
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if any liver disease has been reported . - if your body has increased blood levels of some enzymes of the liver called transaminases . - tell your doctor if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking rilzole zenta : - if : you have any liver problems . - you have yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth once a day , preferably at the same time each day . your doctor may prescribe a lower dose for the 12 weeks after you start taking riluzole zentiva . if you take more rilzole zenta than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take the tablet pack with you . if a dose is missed , take it as soon as you remember .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . a blood sample will be taken to count white blood cell counts . this is important to help protect you from infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor will do regular blood tests before and during
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and marked with ' 50 ' on one side and ' rilzole 202 ' on the other side . ril
what emgality is emgally contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene , which is involved in migraine . increased levels of cgrp in the blood can lead to an increased risk of migraine . what emgalis is used for emgaly is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines are usually mild to moderate . emgali may be used alone or in combination with other medicines to reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can lead to allergic reactions emgally can cause serious allergic reactions . these reactions may be life - threatening . you should see your doctor immediately if you experience 40 signs of a serious allergic reaction . such signs may be serious or life - long . you must report side effects immediately if your doctor suspects any of these conditions . see section 4 . children and adolescents emgali is not recommended for children and teenagers under the
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg injection once daily . emgally should be injected under your skin ( subcutaneous injection ). you may receive your emgalis injection with or without proper training . if you have the impression that the effect of emgal is too strong or too weak , talk to your doctor . if your doctor thinks that the dose is too weak or too strong , talk with your physician . if the dose of 240 mg is too low , talk again . do not take a
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions may affect up to 1 in 1 , 000 people : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash , raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ): injection site pain injection site reactions may include red skin , itching , bruising , swelling . common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . after first opening , the product may be stored for up to 7 days below 30 . do this until the expirment date stated on your blister . do away with the blister after this time period . donot throw away any medicines via wastewater or household waste . ask your
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the solution is clear to slightly opalescent and colourless . the syringe is supplied as single - dose pen . pack sizes of 1 , 2 ,
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels of the liver become damaged and clots become larger . it can be given to patients who have not received medicines prior to a stem cell transplantation . defibrorotide works by helping the blood arteries to open and close , so that the blood clots can be removed . your doctor has prescribed this medicine for you .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor or nurse before using this medicine . warnings and measures if you experience bleeding or heavy bleeding , you may need a blood transfusion or surgery . if you suffer from problems with blood circulation or a constant blood pressure , tell the doctor or hospital pharmacist before using defitilio . children and adolescents do
the treatment with defitelio will be started by a doctor who is experienced in the treatment of stem cells transplantation . it will be given into one of your veins as an ' intravenous infusion ' ( drip ). you will be monitored during this treatment for 21 days until your symptoms improve . if you have any further questions on the use of this product , ask your doctor or pharmacist . children and adolescents do not give this medicine to children less than 18 years of age . if a child swallows some of the medicine , contact your doctor . if the child swallips some of this medicine , tell your doctor immediately . if
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defitelo and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ) low blood pressure common ( might affect up to 1 in every 10 people ): bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine and the mouth bleeding from under the skin coagulopathy ( disturbance in blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not defiteloio if you notice that the infusion storage is not clear or if the solution is cloudy . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrorotide ( as mesilate ). each ml solution provides 80 mg of the active substances in defibotide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections . what defitELio looks like and contents of the pack defitelo is a clear , colourless to pale yellow solution for infusion . it is supplied in a 10 ml vial containing 2 . 4 ml
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklanza are : - combination with daclafenone alone or with other oral medicines to control hepatitis c in adults . - combination of the other medicine with dakinza may improve your response to
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to treat tuberculosis ) dexamethasone ( a steroid used to reduce allergic and inflammatory diseases ) medicines containing st . john ' s wort ( hypericum
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once daily . do not take more than this dose once daily because of the unpleasant taste . daklza may be taken with some other medicines . if you take more daklanza than you should if you have taken more dailinza than your doctor tells you to , contact your doctor . if possible , take these medicines with food . your doctor may increase your daily dose of taklinz depending on how you respond to
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when taking daklineza in tandem with sofiosbuir or ribavir the following other side effects have been associated : very rare ( may affects more than1 in
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of
proquad is a vaccine to protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the body will make antibodies against the diseases that cause mumps and rubella ( varica ). when a child is given a vaccine against varicellis , the antibodies help to prevent diseases caused by these viruses . proquad is intended for adults and adolescents aged 9 years and older . it is used in combination with national vaccination schedules to prevent measles caused by live viruses ( measles , rubellis , chickenpox ). the vaccine is recommended for use in children
do not receive proquad - if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine ( see section 6 ) or to neomycin - if your child has a blood disorder or type of cancer that affects the immune system ( for example , treatment with medications that weaken the immunesystem , e . g . low - dose corticosteroid therapy , asthma or replacement therapy ) - if the child has or has had a weakened immune system - if he / she has a disease ( including aids ) - in case of congenital or hereditary immunodeficiency ( immune competence ) - with
proquad is given by injection into the muscle or under the skin in the thigh or upper arm . injections should not be given into the upper muscle or thigh area or into the arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not go into the skin . bleeding should not occur . proquad should not enter into a blood vessel . pro quad is given as an injection into a vein . adults and children from 9 months of age and older : the recommended dose is one 9 mg dose given once a week . children from nine months of ages and older who have had chickenpox or measles
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) and a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side effect that have occurred with pro quad include : very common ( may affects more than 1 in
what proquad contains the active substances are : measles virus1 , edmonston strain , equivalent to 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , corresponding to 4 . 30 mg rubella virus2 , strain , similar to 3. 00 mg varicella virus3 , merck strain , 3 . 99 mg mrc . the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 what proquad looks like
jylamvo is a substance that is absorbed by the body and is an anticancer medicine that reduces unwanted reactions . it is an immunosuppressive agent . it acts on the body ' s own inflammatory system . jylamve is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( with polyarthritic forms of joints ) severe juvenile idiopathic arthritis ( jia ) in children and adolescents 3 years of age and older . it has been given to you by your doctor to reduce the use of non - steroidal anti - inflammatory drugs ( nsaids ) in patients with
do not use jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you have a severe kidney impairment - if the doctor has given you medicine that contains methotreonate - if a liver impairment has been reported - if there have been blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using jylimvo
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will discuss these with you and will adjust the dose and duration of the treatment . rheumatoid arthritis , severe juvenile idiopathic arthritis , and severe psoriasis . for severe psoriatic arthritis , jylimvo is used as a long - term treatment . jjlamvo is also used for rheumatic and skin diseases , such as jia , psorism and psoriatics
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry st
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the medicine should be administered immediately after preparation in order for accidental spillage . the product should be used within 3 hours after preparation . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydrobenzozoate "). what jyarmvo looks like and contents of
what enurev breezhaler is this medicine contains a substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine prevents this tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor or pharmacist before treatment with enurevi breez inhaler . if you have any of these conditions , stop using this medicine and contact your doctor immediately : - tightness of the chest , coughing , wheezing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used within 24 hours of the last dose . your doctor will tell you how many capsules to use . the maximum recommended dose ( 75 mg ) is one capsule once a week . you should use this medicinal product every day , at the same time each day . how to use this product this medicine comes as an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ). the capsules should be swallowed whole with
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger , frequent urination , rash , itching , hives , difficulty breathing , swallowing , dizziness . allergic reaction ( swelling mainly of the tongue , lips , face or throat ) which may be accompanied by angioedema . other side effects include some sideeffects listed below ( frequency cannot be estimated from the available data ). the following side effects have been
what enurev breezhaler contains the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycoprroniumbromide equivalent to 50 microgram of glycopyronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopirronium per inhalation dose . the other ingredients are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezker 44 microlitre inhalation powder is a white
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this protein , it stops the cell from growing and dividing . riximyo is used for the treatment of several different conditions . ruximyo can be used : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue that affects the immune system . b ) a type a or
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using riximeryo . if any of
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may decide to change your dose . rixima is given as a drip ( intra - venous infusion ). medicines given before each riximusyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor will also tell you how long you will have to take your treatment . if
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number of plate
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient in ritiximab , 10 mg per ml . - the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 " rixamyo contains sodium "). what rixima looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotican actis treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using topotocan activ if your blood cell counts are too low . do not use more topotican actez than your doctor tells you to if you have any kidney problems . talk to a doctor , nurse or pharmacist before using this medicine . warnings and risks talk to the doctor , pharmacacist or pharmaceutian before using any of these : - if topotche
the dose of topotecan actavis you will receive will depend on the disease being treated and on results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer : 1 . 5 mg per square metre of body surface area for 5 days . this treatment cycle will be repeated every three weeks . for cervical cancer : 0 . 75 mg per sq metre of surface area , for 3 days . you will also receive this treatmentcycle for cervical disease in combination with another anticancer medicines , cisplatin . cisplin is given to patients with impaired kidney function . your doctor will determine your kidney
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections very common ( may affect more than 1 in 10 people ): fever . this may be due to your general condition ( local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea , bowel inflammation , neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation rare ( may effect up to 1 in 1 , 000 people ): difficulty in breathing , cough , fever .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 hours at 2 and 8 , when stored in a refrigerator ( 2 - 8 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) has been
what topotecan actavis contains - the active substance is topotecaan . each vial contains 1 mg or 4 mg topotican ( as hydrochloride ). after reconstitution 1 ml contains 1mg topotan . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotecoan actis looks like and contents of the pack topottecan acti is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and a protective sleeve .
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasta works by blocking the enzymes that break down acetyl acetylCHoline : acetylchlorolinescerase and butyrylcholinesternase . by
do not take rivastigmine hexal - if you are allergic to rivasta ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings and risks talk to the doctor or nurse before taking any of your following : - if any patient has irregular or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , your doctor may increase your dose to the highest dose that is 6 . 0 mg / m2 . your doctor should also check your weight regularly while you are taking this medicine . if you have not taken rivasta hexal for more than three days , do not take the next dose until you have talked to your
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below have been observed with rivastigmine hexal : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each ritastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each riastig
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer that has come back after receiving a specific anticancer medicine containing sorafenib . how cabometyx works cabometx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , cabometometyx can kill tumours and cause high amounts in cancer cells .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety if you have high blood pressure , have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall , have diarrhoea , have recent significant bleeding , have recently had surgery ( including dental surgery ), have had or plan to have surgical procedures , or are going to have dental surgery . if you suffer from inflammatory bowel disease ( e
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the correct dose of this medicine and will adjust your treatment if necessary . this will help reduce the risk of serious side effects . duration of treatment your doctor may decide to keep you under the control of cabometyx for a maximum of 60 days . you should take cabometx for 2 days before starting treatment . you may take cabometricyx for 1 hour before or after food . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any of the following side effects stop taking cabometyx and contact your doctor or get other medicines . your doctor may decide to stop treatment if your side effects become severe or uncontrollable . tell your doctor straight away if you notice any of these side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation , fever , as these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or unpredictable bleeding . symptoms include vomiting blood , black
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg contains caboxantinibe . cabobometyx 40 mg : one tablet contains Cabozanthinib (s ) and Malate . each tablets of 40 mg contain cabozANTinib . each adult film - coated tablet of cabometometyx 60 mg : two tablets contain caboxatinab ( s ), and malacy . each film - coating contains 60 mg cabozetinib
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemrexedospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . when pemetreed hospiera is given to treat lung cancer , your disease will respond to treatment and it may
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetezed hospir if you have or have ever had problems with your kidneys . before you receive pemeted hospire , your doctor will check before each infusion that the amount of medicine
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out your dose based on this body surface area and will adjust your dose and frequency of treatment depending on your blood cell counts . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetemetrexED hospira will be given by infusion into one of your veins . the infusion will
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater and sweating ( common ). this is a sign of infection . if you are less than 25 years old and have less white blood cells than normal which is very common . infection ( sepsis ) may be severe and could lead to death . if this happens , tell your doctor straight away . chest pain ( common ) if you get a fast heart rate ( common ), pain , redness , swelling or sores in your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . the reconstituuted solution should be administered immediately after preparation .
what pemetrexed hospira contains the active substance is pemetreed . pemetrxed hospiras 100 mg : each vial contains 100 mg of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetoxed hospiry 500 mg : one vial of 500 mg contains 500 mg of dispemetrexED ( as dispemetreted dis sodium hemipertahydrine ). pemrexedospira 1 , 000 mg : the active ingredient is pememetrexede . pemexed disdisodium hemimeentahhydrate
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which are analogue to a prostaglandin analogue . timolole belongs to medicines called beta - blockers . what ganfort is used for ganatoprist is a clear , watery liquid that is injected into the eye by your eye . it is used in adults , adolescents and children aged one year and above who have glaucoma . ganart eye drops are used to reduce high pressure
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma or severe chronic obstructive bronchitis if you suffer from severe lung disease ( signs include wheeziness , difficulty in breathing , or long - standing cough ) if any of these apply to you , tell your doctor before using ganst . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have coronary heart disease ( symptoms include chest pain ,
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment use the bottle and the mirror before using . twist the bottle around your neck . 5 . 1 . wash your hands . do not touch your head . 2 . pull down your eyelid , which is covered by a small pocket . 3 . gently squeeze the bottle until the drops are in your eye . during treatment , 4 . gently pull down the lid of your eye ( picture 2 ). gently squeeze your eye with a finger until the drop is in your other eye . do this with
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause some side effects . ganart ( multi - dose or single - dose ) can cause very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of the eye which increases sensitivity to light ), eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the solution in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / 0 . 5 ml ) timolol maleate ( 6 . 8 mg / ml ). - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , clear , colourless to pale yellow eye drop supplied in a plastic bottle . each pack
gefitinib mylan contains the active substance gefitinib . this protein is designed to kill cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefnitinibmylan if : you have any other lung problems . some lung problems may be serious . gefinib melan should not be used if you have problems with your liver . gekitin ib mylan should be used in children and adolescents under 18 years of age . other medicines and gefilitinib tell your doctor or pharmacist if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you should take antacids on an empty stomach at least 2 hours before or 1 hour after taking gefitinib mylan . if you have trouble swallowing the tablet , you can crush it and mix it with any other liquids . the total recommended dose for adults is 20 mg once a morning . if your doctor thinks that the effect of gefitoninib is too strong or too
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs ( called ' interstitial lung disease '). uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting your body .
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet coating are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) which can be caused by lack of red blood vessel transfusions . reblozey is used in adults to treat anaemia in patients with mds who cannot receive red bloodcell transfusions ( erythropoietin therapies ) in patients who have already had beta - thalassaemia
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot . your doctor may decide to restart hormone replacement therapy if you had a previous blood clot or if preventive measures ( including medicines ) are not sufficient to prevent a blood clot . high blood pressure if you take reflozyl , your blood pressure
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you use reblozyl . rebluzyl is given as an injection under the skin . the injections should be given at least 1 . 0 cm away from your body weight . your dose will be adjusted by your doctor depending on your blood pressure . use in children and adolescents the recommended dose of rebl ozyl for children and adolescent with myelodysplastic syndromes is the same as for adults . the maximum single dose is 1 . 75
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you have difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision , which may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . very common side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 24 hours at 2 8 . do away with any unused medicinal product or waste material . do this as your doctor or pharmacist has told you .
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution , each mlof solution contains 50 mg of of lsuspatercept in one ml . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack reblizyl is a white to off - white powder . rebloxyl 25 mg powder
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tivuzanib works by stopping the growth of the cancer . it stops the growth and spread of cancer cells by blocking the action of proteins called alpha or interleukin - 2 , which are involved in the development of new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or intratheukin 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a problem with your stomach ( stomach ) or intestines . if you drink alcohol ( see section " warnings and precautions "). if you smoke . if your doctor has told you that you are suffering from high blood pressure . warnings and measures talk to your doctor or pharmacist before taking fotiveda . your doctor will check your blood pressure regularly . your blood will be monitored by your doctor while you are taking a medicine to treat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg for the 21 days followed by 7 days followed with 1 dose of capsules in each 4 - week period . your doctor will decide how many days you should take fotvda . if you experience unacceptable side effects or if you develop severe side effects after the start of fotonivda therapy , your doctor may stop fotovda . the usual dose of the 890 mg dose for the 23 days followed after 7 days is 1 dose (
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension is not treated with a medicine to treat your high blood blood pressure . if you take more fotvda than you
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tiv ozanib ( as tivzanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivoyanib , mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( for strong ammonia solution ) and titanium dioxide , tartrazine aluminium lake ( e133 ). printing ink : shellac , propylene hydro
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antitroviral medication called aucleotide reverse transcriptases inhibitor ( rtrti ). stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv )
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofoviir disopicroxil . your doctor will check your kidney function and may change your dose of these medicines . if you have alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : the recommended dose is 35 mg once a day by mouth . your doctor may change the dose of your medicine or interrupt the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc ) or if you have taken any of these ( see section 4 , possible side effects ). if you forget to take stribild take strastild as soon as you remember unless your doctor
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when you are being treated for hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hiva disease itself or by the medicines you are taking . serious side effects tell your doctor immediately if you experience lactic
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtritabine , 245 mg tenofofovira disoprocessil and 300 mg ten ofovir desoproxel fumarate . each tablet contains 136 mg ten Ofovir . the other ingredients are : tablet core : croscarmellose sodium , hydroxypropyl cellul
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypxa . zypitxa is not recommended for elderly patients with dementia because it may have serious side effects .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . you should swallow the tablets whole with a glass of water . you can take zypxa with or without food . the usual dose is one 5 mg tablet once a morning . your doctor may increase your dose to one 20 mg tablet twice a day depending on your symptoms . swallow the tablet whole with some water . do not chew or crush the tablet . if you take more zypyxa than you should if you accidentally take too many z
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . zyprexa may pose a risk to the environment . do tell your pharmacist if you notice any change in the appearance of the tablets . these measures will help to protect the environment
what zyprexa contains the active substance is olanzapine . each zyprixa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are : - zy prexa 2 .5 mg , 6 mg , 7 . 0 mg and 10
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that attaches to a target in the body . this is another protein that is involved in the process of causing bone loss in patients with osteoporosis . treatment with prolia helps to make bone stronger . it helps to keep the bone thin and fragile . osteopORosis is a condition where osteoporeosis is caused by low levels of testosterone and glucocorticoids . osteooporism has symptoms such as breaking bones , especially of the spine , hips and wrists , and may occur more easily if you
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , or if you get any of them , talk to a doctor or nurse straight away . if any of those apply to your child , tell your doctor straight away before using this medicine . warnings and symptoms talk to the doctor or healthcare professional before using it if your child has a skin infection with
what prolia is prolia contains one pre - filled syringe 60 mg / ml ( 0 . 5 ml ) solution for injection , which should be given within 6 hours . it is given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . if you use more prolia than you should if you have used more prolias than you have been told to , tell your doctor or pharmacist . if possible , you should wear stickers to remind you to take calcium and vitamin d supplements . if necessary , you can take them with or without food . how much prolia
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor immediately if you notice any of the following skin infections ( cellulitis ). these symptoms may be due to prolia : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . stop using prolia if you have pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), which may be signs of bone damage in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be removed from the refrigerator and left at room temperature ( not above 25 ) for a single period of maximum one month . after this period , the injection may be stored at room temperatures ( not below 25 ) or at room room
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg of denosumaab , corresponding to 60 mg / ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . ambirax works by blocking two proteins that the virus needs to grow and reproduce itself . the virus can infect faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches , pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice
you must not be given ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath , swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you are given ambira if you : have ever had hepatitis a or hepatitis b diseases . have a severe infection with a high temperature . the vaccine should be given at the same time as a
your doctor or nurse will give you ambirix as an injection into a muscle ( usually in the upper arm ). ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . you may be given the first injection at least one month after the second injection . you should be careful if you miss a scheduled injection . if you stop receiving ambirax if you have any further questions on the use of this product , ask your doctor or pharmacist .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain or redness where
what ambirix contains 26 the active substances are hepatitis a virus ( 1 , 720 micrograms / ml ) and elisa units ( 4 , 000 microgram ) of hepatitis b surface antigen ( 4 . 20 microgram / ml ). the other ingredients are human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirrix is a white
what bexsero is bex serumo is a meningococcal group b vaccine . bex sero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are responsible for causing infections ( such as meningitis and inflammation of the brain and spinal cord ) and for the cause of sepsis ( blood poisoning ). the vaccine works by helping the body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using bex serumo if : you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . vaccination should not be delayed until you are fully recovered from haemophilia . you have any other problem that may prevent your blood from clotting properly . you are taking blood thinners ( anticoagulants ) or treatment that supp
your doctor or nurse will give you bexsero at the dose recommended by your doctor . the recommended dose is 5 mg injected into a muscle ( usually in the thigh or upper arm ). injections will be given at least 2 weeks apart . the first dose will be administered at least 5 weeks apart and three injections later . the vaccine may be given as an additional injection ( booster ). the first injection will be postponed until 2 weeks after the interval between injections . this will take 1 month . the intervalbetween injections will take 2 months . your doctor will give a booster . children and adolescents from 12 years of age and above 15 years of
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the injected site , hardness of the surface of the injected area . if any of these affects you , tell your doctor . other side effects may occur with this vaccine : common ( might affect up to 1 in every 10 people ) fever , loss of appetite ,
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitidas group b noada protein 1 and 2 , 2 and 3 50 micrograms recombinant neurisseria meingitis group b fhbp fusion protein 2 and 2 and three 50 micros recombinating neissia meningitsidis groupb fhba infusion protein 1 or 2 , and 3 , 50 micromgrams recombinating nissia maningitsis groupb strain ( total
nitisinone mdk contains the active substance nitisinon . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hae ) in adults , adolescents and children from 1 year of age . due to this disease your body cannot break down the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone helps to break down tyrosinine and the harmful substances it produces . this means that tyrosino is eliminated from the body by low tyrosines , such as phenylalanine ( another amino acid ).
do not take nitisinone mdk - if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitisinaone md k is not recommended for use in children . your doctor will check your eyes before and during nitisinfone treatment . if you develop red eyes or other problems with your eyes , tell your doctor immediately . your physician may recommend an eye examination . if possible , your doctor may decide to delay or stop nitisino dose . inadequate diet (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day . the dose may be increased to 20 capsules once a week . in this patient population , swallowing the capsules may be taken with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . do away with the blister if you notice it is not warm or there is a temperature below 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitisatinone md k 2 mg : each capsule contains 2 mg nitisine . nitesinone dk 5 mg : one capsule contains 5 mg nisinone . nisinnone dzk 10 mg : the active ingredient is nitesino . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinnone mdks looks like and contents of the pack nitisinaone mdky capsules are 15 . 7 mm long , hard gelatin capsules
the name of the medicine is docetaxel accord . docetxel accord is a substance derived from the needles of yew trees . doceteaxel belongs to the group of anti - cancer medicines called taxoids . docelaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer : docetixel could be administered either alone or in combination with doxorubicin , or trastuzumab ,
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if white blood cells are low - if your liver is not working properly - if there is a severe liver disease warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacel accord . white blood cell disturbances may cause fever and infections . tell your doctor immediately if you have abdominal pain , tenderness , diarrhoe
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you will usually receive your infusion once every 3 weeks . your doctor will take a number of different measures , including : - the results of your blood tests and yourgeneral condition . docetacel accord may be given in the presence of diarrhoea , sores in the mouth , feeling
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be increased when docetacel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . donot store above 25 . store in the original package in order to protect from light . the vial should be used immediately after dilution . the medicine should be transferred from the infusion bag to the infusion vial within 6 hours ( corresponding to 25 hours of infusion ). the infusion solution should be stored in non - pvc bags for 48 hours ( equivalent to 2 to 8 ). do not freeze
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetel . 1 vial of concentrate contains 20mg docetixel . 4 vials of concentrate contain 80 mg docel . 8 vials ( concentrate ) ( concentrate contains 160 mg docotaxel ). - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol an hydrous "), citric acid anhydrated ( see also section 2 ) what docetAXel accord looks like and contents of
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . this medicinal product acts by causing the brain to relax , allowing the body to react more normally . this means that the brain is able to react normally to stimuli it is able more effectively . this is called attention deficit hyperactivity disorder ( adhd ). this medicine is used to treat adults who are unable to take current stimulation and whose adhd symptoms are not controlled enough with the medicine . intuniv is used in combination with a treatment programme consisting of psychological therapy , educational therapy and social therapy
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunive if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you have ever fainted or have recently had thoughts or feelings of suicide . tell your physician if you know or have any other psychiatric conditions or withdrawal symptoms . increased heart rate or highblood pressure tell your healthcare professional before taking this medicine if any of these problems occur . children and adolescents intuniveriv
your treatment should be started under the supervision of a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be adjusted by your doctor depending on how you respond to treatment . the dose may be increased or decreased depending on your response to treatment : the recommended starting dose is 0 . 05 mg / kg of bodyweight once daily for the first 7 days . your treatment may be continued for up
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor or pharmacist straight away . your doctor may need to adjust your dose of your medicine . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephal
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within the first week of opening the blister pack . do this if you notice any change in the appearance of the tablets . do away with the blister packs . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each extended - release dose contains 2 mg of Guanfacin . each long - release episode contains 3 mg of the active substances guanfuine hydro chloride . each continued - release dosage contains 3mg of guinfacine . every extended -release episode contains 4 mg of of gufacine ( see section 4 for further information on guanfinine ). the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate cop
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with fungal infection of the blood or other internal organs ( invasive candidiasis ). it works by preventing the infection of fungal cells called candida by blocking their growth . ecalta belongs to a group of medicines called echinocandins . these medicines are used to prevent serious fungal infections caused by fungal cell walls . ecalda is used when fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to reduce the dose you receive , or stop your treatment temporarily , or to give you anaesthetics . your treatment with ecaltas may need to be temporarily stopped . if you experience an allergic reaction such as itching , wheezing , blotchy skin , you should
the treatment will be started by a doctor or nurse who is experienced in the treatment of patients with a combined total of 200 mg and 100 mg . the recommended dose is 1 mg per kg of body weight . adults and children aged 1 year to 18 years : the recommended starting dose is 3 . 0 mg per kilogram of bodyweight . the dose may be increased to 200 mg , 1 . 5 mg or 100 mg perkg of body mass depending on the patient ' s weight . ecalta is given as slow infusion ( a drip into a vein ) over a period of 1 . 4 to 3 hours . the loading dose will
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . the infusion solution should not be stored above 25 for longer than 48 hours . if refriger
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a substitute for pegylated human coagulation factor viii . the human coaggulation factor iii is produced naturally in the body . factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced naturally . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to any of these ingredients . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno . allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing ,
treatment with adynovi will be started by a doctor with experience in the care of patients with haemophilia a . adynov is used for treatment of bleeding . your doctor will decide whether adynova is suitable for you . the replacement therapy with adnovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . dosage and prevention of bleeding the recommended dose of adyniovine is 40 mg once a day . your dose may be increased to 50 mg once daily for 2 weeks . prevention of blood - related bleeding the dose
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is immediately available . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . do this medicine if it is not used within 3 months or if it has been stored at a room temperature not above 30 for a longer
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial provides 5 ml of sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , polys
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs , in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they are produced by the ovaries and are involved with the development of many egg sacs .
do not use this medicine if you are suffering from your fertility problems . if you think you may be allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus if you develop enlarged ovaries or cysts on your ovaries if you suffer from polycystic ovarian disease if you experience bleeding from the vagina at an early menopause if you had malformations of the sexual organs ( see section " pregnancy and breast - feeding "). if you or your partner have fib
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will prescribe anti - müllerian hormone to stimulate your ovaries to produce stimulation with gonadotropins . the dose will depend on your blood weight . your dose will also be calculated from a blood sample taken every 12 months . the duration of treatment depends on your body weight . the first dose of treatment will be administered as your second dose . the second dose of the recovelledose will be injected as
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation sensation ) pelvic pain and discomfort ( ovarian origin tiredness and fatigue
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 for a single period of up to 3 days . after this period , the product may be stored at room temperature ( up to 28 ) for up to 25 days . during the treatment any unused solution must be discarded . do away with medicines that are no longer being used . these measures will help protect the environment .
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after reconstitution , each ml of solution contains 33 . 3 mg of of folliotropin delta in each millilitere of solution ( corresponding to 0 . 35 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrine , concentrated phosphoric acid , sodium hydroxide and water
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptone contains either flutic asone fureate 92 mg or vilancerol 22 mg . fluticAsone furesate 184 mg and vilterol 22mg are used for 92 / 22 chronic obstructive pulmonary disease ( copd ). asthma in adults and adolescents 12 years of age and older weighing 184 kg or more : 184 / 22 copd is a category of asthma that occurs every 12 months and which is not controlled with other treatments . asthma in adolescents
do not use ellipta if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ellipta . ellipta should not be used if you have liver disease . if you experience side effects if you suffer from moderate or severe liver disease , the lower strength of revinty ellipta 92 / 22 mg may be appropriate for you . if any of these apply to you , tell your doctor . if your doctor has told you that you have heart problems , such as high blood
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhalant each day ) with fluticasone furoate and 22 mg vilanterol . for copd the recommended starting dose for flutic asone firoate and 21 mg vilterol is one inhale twice a morning ( one tablet each day ). for copdi the recommended daily dose for the treatment of fluticusone froate and 23 mg vileterol
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face and mouth ( angioedema ), feeling very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ) immediate breathing difficulties if you have immediate breathing difficulty while taking revinty ellipt
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each inhalation provides 92 doses ( 92 micrograms ) of flutic asone firoate and 22 microgram ( 23 microgram ) of vilancerol ( as trifenatate ). each 184 microgram inhalation delivers 184 doses ( 184 microg ) of Fluticason furoATE and 22 mg of vilterol (as trifnatate ) respectively . the other ingredients are lactose monohydrate ( see section 2 under ' revintchy ellipta contents
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , a nucleotide reverse transcriptatase inhibitor . these active substances are all given together with antiretroviral medicines . they work by interfering with the activity of an enzyme ( reverse transcriptasing ) that is essential for the virus to multiply . atripla is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects may be more serious . if you experience dizziness or drowsiness while taking atrilea , contact your doctor . if possible take your tablet atriblea with food . atrapla can be taken with or without efavirenz , emtricitabine or tenofov
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and seek medical help immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavenirenz and 200 mg emtritabine , 245 mg tenofoviir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atribla contains sodium "). the tablet film coating contains
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophine releasing hormone ( gnrh ). gonadotropin regulates the release of gonadots and follicle stimulating hormone . gonadrophins are involved in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells in the sacs . they are then grown in fertilised eggs ( follicles ) in the laboratory and
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other gonadote analogue . - if your child has a moderate or severe kidney or liver disease . - are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if you develop an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions : allergic reactions are generalised ( hives , urticaria
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is only used for the treatment of women with assisted reproduction techniques , including in vitro fertilisation ( ivf ), ovarian stimulation ( follicle stimulating hormone ), corifollitropin on day 2 or day 3 of each cycle . orgdalutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . your doctor will decide how many cycles of treatment you need . your dose of orgaluitran will depend on your response to fsh . the preparation
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . see section 4 for more information . uncommon ( may affect up to 1 in 100 people ) headache nausea ( malaise ) rare ( may affects up to one in 10 , 000 people ) allergic reactions including rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , which may cause difficulty in breathing or swallowing ( angio
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , liquid - free solutions . do away with any unused syringe after first opening . do this to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of solution . - the other ingredients are acetic acid , mannitol , water for injections ( for the ph ), sodium hydroxide and acetic acids . what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution . the solution is clear and colourless . it is for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . each pack of orgalustran contains 1 or 5 vials
what blitzima is blitzima contains the active substance rituximab , a " monoclonal antibody ". this is a type of white blood cell that sticks to a target in the body . when ritukimab sticks to the target , the cell dies . what blitzima used for blitzima has been prescribed for the treatment of : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue that affects the immune system . a ) a type a or b - lymphocytes . blitzima can be used alone or in combination with other medicines called " chemotherapy ". the treatment
do not use blitzima if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor or pharmacist before using blitzima : if you currently have granulomatosis , polyangiitis , microscopic polyangioniitis or pemphigus vulgaris . this is because you
how much blitzima is given your doctor will decide how much blitzim you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may lower your dose . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your doctor can also change the dose of your treatment depending on your condition . if
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritudimab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials containing 50 ml . pack size of 1 vial .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the immune system . this target is found in the cells of the body and causes the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactorra reduces the damage to the cartilage and bone in your bones caused by the disease . roacticemra is used to treat moderate to severe active rheumatoid arthritis , an autoimmune disease that has not responded to previous therapies . roacem
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . these reactions usually disappear within a few days . if you notice any of these , tell your doctor or nurse immediately . infections tell your doctors immediately if you feel unwell . roactemara may affect your body ' s
the doctor or nurse will give you roactemra by infusion into a vein , usually by a nurse . the intravenous infusion will last about one hour . your doctor will decide how long you should receive the treatment . the recommended dose of roactlemra is 8 mg per kg body weight . the usual dose is 4 mg per kilogram body weight given once a week . the dose of 8 mg given once weekly is 4mg per kg of body weight administered once a day . the maximum recommended dose is 8mg per kilter body weight , given once every week . your dose of 30 mg given every 12 weeks is 30
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in patients taking the medicine ( see section 3 " warnings and precautions "): roactemnra may cause serious side effects ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( may occur in
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 mg . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg ). each 20 ml vray contains 400 mg of the active substances in tocilixumab 20 mg ( 20mg ). the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack ro
what onbrez breezhaler is onbrex breez inhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breezcheler is used for onbrezer is used to treat breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine works by relaxing these muscles in your lungs . it helps to open the air passages wider and makes it
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer : - if the patient has heart problems , epilepsy , thyroid gland problems , thyrotoxicosis ( diabetes ). treatment with on brez breezerhaler should be stopped immediately if you get tightness of the chest , coughing , whe
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the 150 microgram capsule is for oral use . the 300 microgram capsules are for inhalation use . your doctor will tell you how long you should continue the treatment with your inhaler . use within 24 hours of your first dose of onbrez breezhaler . you will need to use an inhaler and capsules ( in blisters ) to inhale the medicine . the medicine is inhalation powder . the onbreez breez inhaler is for inhalatory use only . do not use
what onbrez breezhaler contains - each onbrex breez inhaler 150 micrograms inhaler contains 150 microlitres of indacaterol as indacate . - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 microgramS inhaler 300 microlitre inhaler includes 300 micrometres of of indiacaterol ( as indaconateol maleate ). - the ingredients are made of lactoseand the capsule contains gelatin . what onbreez breezeler looks like and contents of the pack onbre
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events (
do not take clopidogrel hcs - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your bleeding is not being controlled with other medicines . - if there is a risk of bleeding such as : - a stomach ulcer or bleeding within the brain . - severe liver disease . if you think any of these apply to you , or if you have any other medical conditions , tell your doctor . warnings and precautions take special care with clopridogrel clcs if any of your situations apply to your , or you are at risk
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc
feccroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja helps to stop infections caused by bacteria that you have not previously fought with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). if this happens , tell your doctor straight away . if you develop severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , tell
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours . it may take up to 2 weeks for fetcroja treatment to work . your doctor will check you for infection . if your infection is not well controlled , you may be given another medicine . if you get any pain during the fetcrofa infusion , it is usually given by another doctor or another nurse . it is recommended that you continue to receive fetcrora for as long as your doctor prescribes it for you . if kidney problems are reported , your doctor may decide to reduce your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . if you have this reaction , you may have diarrhoea , stools , blood or mucus , which may be very common at the start of treatment or if you are taking medicines to slow bowel movement . other side effects include : very common side effects ( may
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefingerocol . the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojia is a white to off - white powder for concentrate for solution for infusion . it is available in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatinous menenitis is a condition in which tumour cells form the membranes of the brain and spinal cord . depocyte is prepared from lymphoma tumour cell material .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions talk to your doctor or pharmacist before using depocyte . severe neurological side effects have been reported with depocyte , with symptoms affecting the nervous system such as convulsions , pain , numbness , tingling , blindness , visual disturbances . if you experience any of these symptoms , stop using any dexamethasone tablets and contact your doctor immediately . unwanted effects your doctor will monitor your side effects and
treatment of cancer in the lumber sac will be overseen by a doctor who is experienced in the use of depocyte . depocyte will be given to you by a qualified healthcare professional . the recommended dose is 1 vial of 5 mg of dexamethasone 5 mg / ml . each depocyte dose will be monitored by your doctor to detect any side effects . depocytes will be diluted by temperature 22 to 30 minutes before withdrawing depocyte from the vial . proper precautions should be taken to avoid exposure to a cytotoxic drug . proper handling technique is used to ensure that depocyte is withdrawn within 4 hours of withdrawal .
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these side effects with you and will explain the risks and benefits of your treatment . the most frequently reported side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very common : affects less than 1 users in 10 not known ( frequency cannot be estimated from the available data ) very rare : affects 1 in 10 users not known : frequency cannot estimated from available data very common adverse events where depocyte is administered
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . depocyte should be used within 4 weeks after first opening . depocytes should be discarded if the medicine has not been used within the last 4 weeks . do this if you notice that the solution is discoloured or shows signs of a changed appearance . if the solution contains particles , it should be disposed of in accordance with local requirements . if depocyte is used in combination
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarabiline . each vial of depocyte 5 ml contains 50 mg cytabine ( as cholesterol , triolein ), dioleoylphosphatidylcholine , dipalmitoylophosphatidoylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied as a 5 ml clear glass vial . it can be divided into equal doses . it may be available as
what bemrist breezhaler is bemist breez inhaler contains two active substances : indacaterol and mometasone furoate . indacterol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone furyate belongs to the group of medicine called corticosteroids and belongs to an important group of steroids . corticoplastics reduce the swelling and irritation ( inflammation ) in the small airways in the lung , which can lead
do not use bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using bemrid breez inhaler if : you have heart problems , such as an irregular or fast heartbeat . you have thyroid gland problems . you suffer from diabetes . you drink alcohol excessively . you smoke . you are prone to high blood sugar ( seizures ). you have a low level of potassium
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . you should take the medicine at the same time each day . if your asthma does not improve or your symptoms get worse , contact your doctor . how bemrid breez inhaler is for inhalation use . be mrist breezezhalzer is for use in adults . you will need an inhaler and capsules to use the medicine . the inhaler should be used when you are using the medicine , not when you have
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include the following listed below : very rare ( may affects more than1 in 10 , 000 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation contains 173 microgram indacate . each capsule contains 150 microgram of indacatesol and 80 microgram mometsone furyate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 micrograms of indaceaterol and 62 . 4 microgrammometasony furoates .
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis . atherophrombotic events can include stroke , heart attack , or death . you have been
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking zylltt . warnings and precautions talk to your doctor or pharmacist before taking the combination of zyllT and other medicines if you : have a risk of bleeding such a medicalcondition that puts you at risk of internal bleeding ( such as - a stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily dose is one one 75
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllT contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the film - coating ; tablet coating : hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in thefilm - coating .
lamivudine teva contains the active substance lamivudrine . lamivudaine teeva is used to treat long term ( chronic ) hepatitis b infection in adults . lamibine tella is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " means that it causes liver damage . lamlivudineteva reduces the amount of hepatitis b in your body . this results in a reduction in liver damage and
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamividine tevas , like other similar medicines , can cause serious side effects , especially if you have liver disease ( such as hepatitis c . - if your body is overweight ). your doctor will do blood tests before you start your medication and regularly during treatment ( see section 4 , " warnings and risks "). if you take more lamivuxine teeva than you should if you accidentally take too many tablets , or if someone else accidentally
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you keep taking it every day until your infection is gone . this will help control your illness . you should continue to take lamivodine tevas every day as long as your health continues to improve . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much lamivuda teva to take the usual dose of lamivu
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy with lamvudine are : - tiredness - respiratory tract infections - throat discomfort - headache - stomach discomfort - pain - nausea - vomiting - diarrhoea - increases in liver enzymes - the level of enzymes in the muscles - allergic reaction ( rare , may affect up to 1 in 1 , 000 people ) - swelling of eyelids , face or lips , difficulty swallowing or breathing contact
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after first opening . do this if you notice that the tablets are damaged or if there are particles in them . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivu . each film - coated tablet contains 100 mg of lamivude . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed with " l "
nespo is an anti - anaemic ( means that it is used to treat your anaemia ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by blocking the effect of the natural hormone erythropoietin . erythrothropoioietin is produced by your kidneys and stimulates your bone marrow to produce more red bloodcells . it is given in combination with darbepoetin alfa . chronic renal failure ( symptomatic anaemia ) chronic renal fail is caused by kidney failure . kidney failure
do not use nespo if you have high blood pressure or are taking other medicines that are allergic to nesp ( darbepoetin alfa ) or r - huepo . if you suffer from high bloodpressure and are taking medicines to treat sickle cell anaemia . if your child has epileptic fits ( seizures ), convulsions or fits . if he / she has liver disease . if any of the above applies to you , tell your doctor before using drugs to treat anaemia , as nespos may not be suitable for you . if the child has an allergy to latex . the needle
your doctor will carry out blood tests before you start nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemogl level of 10 mg every 10 to 12 hours using the pre - filled syringe . this is given into a vein . if you have chronic renal failure , your doctor may give you a single injection under the skin or into a veins ( intravenous ). the dose will depend on your anaemia . the dose of nespos given will depend upon your body weight . the recommended dose is 0 . 75 mg / kg or 0
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : very common ( may affect more than 471 people ) uncommon ( may affects up to 10 in 100 people ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon : ( may effect up to 1 in 100 , 000 people ) blood clots ( thrombosis ) pain in the area injected rash , redness and / or swelling of the skin rare : ( might affect up to1 in 10 , 000 users ) serious allergic reactions sudden life - threatening allergic
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening of your syringes , you may store nespos at room temperature ( up to 30 ) for a maximum of 7 days . do this at the end of this 7 - day period . do away with nespen after
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the active substances darbasic and sodium phosphate monobasic , sodium phosphate dibasic and water for injections are contained in the solvent . the other ingredients are sodium chloride , polysorbate 80 and water to injections . what nespos looks like and contents of the pack nespi is a clear , colourless to slightly pear
macugen is a solution for the treatment of macular degeneration in adults . this medicine prevents abnormal formation of new blood vessels in the eye . macugen is used for thetreatment of macul degeneration . people with this disease have vision loss caused by damage to a part of the retina ( macula ) in the front part of their eye . the macula is the thin layer between the eye and the retina . macula makes the macular , the thin part of your eye , grow . this new blood vessel can bleed or leak fluid causing the maculas to bulge , distorting or destroying central vision . macug
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have had an infection or bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these happen , tell your doctor straight away . if the following symptoms occur , contact your ophthalmologist immediately : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased
mugen will be given to you by a doctor or nurse . injections of macugen will usually be given by a single injection into your eye . the recommended dose is 6 to 9 injections per day . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). your doctor will decide how much macugen you need . your doctor may also give you antibiotic eye drops to clean your eye and / or your eyes . your healthcare professional will give you some local anaesthetic ( numbing medicine ) to reduce any pain you may have after the injection . if you are allergic to antibiotic eyedrops
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in section 4 . if you experience any of these symptoms
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the medicine in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection is a single dose pack supplied in a pouch . each pack contains a pre -filled syringe (
kipivance contains the active substance palifermin , produced by biotechnology in the laboratory of escherichia coli . palifermine works by stopping the growth of epithelial cells in the mouth and digestive tract and in the tissues of the skin . paliflate is used to treat oral mucositis , which causes soreness and dryness , which is a common side effect in patients receiving treatments for your blood cancer . if your blood cancers are not being treated with chemotherapy , radiotherapy or autologous hemopoietic stem cell transplantation ( a procedure in which blood cells are removed from the body to
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents kepivalance is not recommended for use in children and teenagers under 18 years of age . other medicines and kepvelance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . kepiverance may affect the way some other medicines work . tell your pharmacist before taking heparin
how kepivance is given your doctor will decide on the dose you will receive . your doctor or nurse will decide the dose of cancer treatment you will be given . the recommended dose of kepvance is 60 mg . your dose of kpivanced will be calculated by your doctor based on the kilogram you weigh . it will be administered as an intravenous injection into a vein . how kepvelance is administered kepervance is usually given to you on three days before chemotherapy ( chemotherapy and radiotherapy ) and three days after chemotherapy ( radiotherapy ). the first dose of chemotherapy andradiotherapy will
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth and tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and increased levels of digestive enzymes in the bloodstream .
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder for concentrate for solution for injection . each pack contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitet which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconalcate accordphira is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis because they cannot take waste products to reduce the amount of calcium in the bloodstream ( hypercalcaemia ). to treat parathy thyroid cancer that causes
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly while you are taking cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking cicalcvet accordphara : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of seizures
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . you should swallow the tablet whole with a glass of water . you can take cinaccalcvet accordpharm with or just after food . the tablets should be taken with or shortly after a meal . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual starting dose of cinacealcord
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - numbness or tingling around the mouth , muscle aches or cramps , seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). - swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). these side effects are very common ( may affect more than 1 in 10 people ) and may include nausea and vomiting . if you notice any of these side effect , contact your physician immediately
what cinacalcet accordpharma contains - the active substance is cinacealc . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaconalcate ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcel accordpharmaceutical looks like and contents of the pack ciniac
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformined and biguanides . they work together to lower blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflozin ) or with insulin .
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has severely reduced kidney function . - if he / she has uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . - this could lead to lactic acidosis ( see section " risk of lacticacidosis " below ). what is ketoacidosis ? keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin or metformine , do not take this medication and take your next dose at the usual time . if this medicine is not suitable for you , you may experience an upset stomach . the recommended dose is one 5 mg linaglptin tablet once a day with food , and one 2 , 000 mg metformina hydrochloride tablet once daily . your doctor will
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and see a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglycemia is very rare ( may affect up to 1 in 10 , 000 people ). the most serious side effect reported with jentadoueto plus sulphonylurea is due to the combination jentadaeto
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the blister in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformine hydrochlorides . - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jentudueto looks like and contents of the pack jentaden
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants works by reducing the amount of hiv in your body . it is used in combination with hiv medicine in adults and adolescents aged 12 months and older , who are infected with hick . edhurant is not a cure for hiv . your doctor will discuss with you whether you
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital ), phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) omeprazole , esomepraz
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents ( aged 18 years and over ) the recommended dose of edurant is one tablet once a day . do not take more than one tablet twice a day if you have the impression that the effect of edhurant is too strong or too weak . rifabutin is a medicine used to treat some bacterial infections . if you take more edurent than you should if you accidentally take more rifabiutin than you have been told to , talk
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or problems with your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpalpiviraine hydrochloride . each film - coated tablet contains 25 mg of ril pivirrine . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . tablet coating : the film - coating contains lactosemonohydrate , hypromellose 2910 ( e464 ) and 6 mg of titanium dioxide ( e171
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type 2abetes either don ' t make enough insulin or their body does not make enough of a sugar - free medicine to control their blood sugar levels . they work together by either making the insulin that your body makes , or by blocking the effect of another medicine called a sulphonylurea ( another medicine for diabetes ).
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . your doctor may need to change your dose of avandamet . do not take avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is usually taken once a day in the morning and once a week in the evening . the dose may be taken from 1 to 8 weeks after beginning treatment . the maximum dose is 4 mg rosciglitizone ( corresponding to 1000mg metformina ). thisdose is usually given from 1 week to 8 months after beginning therapy . the dosage may be
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet can include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamand and seek medical advice straight away . lactic acidosis ( a build - up of lacticacid in the blood ( lactic acidicosis is a common side effect in patients taking metformin , especially if you have severe kidney disease ). symptoms of lact acid
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do tell your pharmacist if you are concerned that the tablets may have changed or are not working .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon ( 500 mg ) metforman and 2 mg rosciglitazaone ( 500mg ) met formin . each 2 mg tablet contains rosigslitazona ( 1000 mg ) and met formformin , each 4 mg tablet contain rosIGlitazion ( 1000mg ) and meetformin ). the other ingredients are sodium starch glycollate , hypromellose , microcrystalline
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrelmylan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events (
do not take clopidogrel mylan 31 if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if you think any of this applies to you ( or you are not sure ), talk to the doctor or
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopideogrel melan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ). it is used in adults , adolescents and children ( 12 years of age and older ) to prepare a medical procedure to stop bleeding . it works by reducing the number of platelets in the blood . platelets are a type of blood cells that are involved in helping the blood to clot and stop bleeding from occurring .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using doptelelet if : you have a history of blood clots ( especially in the veins or arteries ) you have had blood cl clots before ( including blood clops in cancer ) you are taking the contraceptive birth control pill or hormone replacement therapy you have recently had surgery or are seriously injured 23 you are overweight or have advanced chronic liver disease you are not sure if any of these apply to you ( or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose of doptelets may be increased to 20 mg , 40 mg or 60 mg once a week . your physician may increase the dose to 5 mg once daily depending on the response to your platelet counts . swallow the tablet whole with a glass of water . do not chew or crush the tablet . do this
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg of avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 under ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries ( heart rate ) and the muscles in the heart . rapiscan is used for a type of heart scan called ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken using a machine to scan the muscles of the heart using a readmill . a scan contains a small amount of radiopharma that is injected into the body ( intravenously ) into a vein . it is given to you by your doctor or nurse to make images
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease or a pacemaker that does not work properly , chest pain ( unstable angina ), or treatment for low blood pressure ( hypotension ) or heart failure . if you are allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before using rapiscen if any of these apply to you : if you : have a recent serious heart problem , including a heart attack , have abnormal heart rhythms ( a heart rhythm where the heartbeat is very
rapiscan will be given to you by a doctor or nurse who is experienced in the care of patients with a history of problems with your heart . the dose will depend on your heart rate and blood pressure . the recommended dose is 400 mg given as a 5 ml solution the injection will be administered over a period of 5 to 10 minutes . the doctor will decide how much rapiscan you need based on your weight . the other dose is an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( 0 to 5 ml ) given as an injection . rapiscin is a radioactive substance ( radi
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and usually disappear after the rapiscin injection has been given within 30 minutes of any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be a sign of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . rapiscans may cause a stroke or cerebrovascular accident
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction ( impotence ), a condition in which a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not been prescribed any of these medicines , please contact your doctor . - if the doctor has prescribed nitric oxide donors such as amyl nitrite , which can lead to an increased risk of a dangerous drop in yourblood pressure . -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . viagra film - coated tablets are for oral use . viag orodispersible tablets are also for oral administration . swallow the tablets whole with a glass of water . do not crush or chew the tablets . viaga can be taken with or without food . swallow your tablets whole . do this with water . viago can help you to get an erection if you get sexually stimulated . if you take more viagra than you should if you accidentally take too many tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if you experience any of the following side effects after taking viagra : an allergic reaction ( may affect up to 1 in 100 people ): symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat . chest pains may be severe and you may need to be in a semi - sitting position . you may also be given nitrates to relieve your chest pain . prolonged and sometimes painful erections ( may occur rarely , may
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : treat the symptoms of primary parkinson ' s disease in adults ; in adolescents ; in children ; in adults . it can be used alone or in combination with levodopa . treat parkinson ', s disease is associated with the symptoms in adults with moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sifroll if you have any medical conditions or symptoms , such as kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). if you suffer from advanced parkinson ' s disease , you may be given levodopa to reduce dyskineia . warnings and symptoms talk to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , take 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg ) once a day . thereafter , take one tablet of 1 tablet sifol 0 .088 mg ( 1 . 264 μg ) once daily . if your symptoms return after this time period , you may take two tablets of 1 tablets of sofrol 0. 088mg ( 0. 264 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( might affect up to 1 in 100 people ) uncommon ( may affects up to1 in 1 , 000 people ) rare ( may effect up to one in 10 , 000 patients ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , you may experience the following side effects : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ), dizz
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , in 0 . 7 ml of solution . the other ingredients are pramipxole 0 . 125 mg , 1 mg , 2 mg , 3 mg , 4 mg , 5 mg , 6 mg , 10 mg , 20 mg , 30 mg , 50 mg , 60 mg , 100 mg , and 100 mg . what sifroll looks like and contents of the pack sifol 0 . 019 mg tablets are white to off - white , round ,
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur when the body has a natural reaction to some materials ( allergens ). allergic reactions may include itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . do not try to cover them with any other contact lenses . if any of the signs of allergic conjjunctivitus occur , contact your doctor straight away . some materials may cause allergic reactions such as itching , yellowing and swelling of the surfaceof your eye that may make you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadadine . children and adolescents do not give this medicine to children under the age of 3 years because benzalkonium chloride has been shown to interact with emadin in children and teenagers under the ages of 6 . clinical trials have not been performed in children under 18 years of age . talk to a doctor or nurse before using this medicine if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use one drop twice a day ( morning and evening ). use in children and adolescents ( 3 years of age and older ) use in the same eye as adults . this medicine is for oral use . use in adults and children ( 12 years of old and older ), adolescents and children weighing at least 1 kg and adults . children and teenagers ( 12 to 17 years of years ) use the emadine bottle as described above . wash your hands before using it . remove the bottle from the
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops can cause them . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects in adults ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye . general side effects : headache , difficulty sleeping , sinus headache , bad taste , rash . generalside
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains the active substance is emadastine 0 . 5 mg / ml . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels ( ph levels ). what emadrine looks like and contents of the pack emadidine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop -tainer ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetir acetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). leveiracetaman is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). levantiracetamer has been
do not take levetiracetam actavis - if you are allergic to levetiraacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking leveturacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported . anti - epileptics should not be used in children and adolescents . levetiralacetam actsavis has been associated with thoughts of harming or killing themselves . tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet of 1 , 000 mg once a day ( monotherapy ) the usual starting dose is 3 , 000 micrograms once a morning . your doctor may increase your dose to one tablet once a week ( monorodicated ) of 1, 000 micrograms once a daily . after therapy dose in children
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms and a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests ( a type of white blood cell ) 56 eosinophilia ( enlarged
what levetiracetam actavis contains the active substance is levetoracetam . levetiraacetamactavis 250 mg : each tablet contains 250 mg of leveturacetam ( as levetaracetam ). levetvetiratam activ 500 mg : one tablet contains 500 mg of the active ingredient levetouracetam. levetmiracetam actingavis 750 mg : the active substances are levetviracetam and amylase . leveriracetamine actavis 1 , 000 mg : every tablet contains 1 , 500 mg levetiralacetam the other ingredients are
incruse ellipta contains the active substance umeclidinium bromide which belongs to a group of bronchodilators called bronchiolators . incruse eflowa is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become blocked , leading to breathing difficulties . incrapse ellipte works by reducing the amount of air that gets in and out of the lungs . this helps to control your breathing difficulties and helps you breathe better . if you have copd , ellipta can help to stop
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using incrusey ellipta : if you have asthma . incruesse ellipta should not be used in patients with asthma . if you suffer from heart problems . if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). if you know that you suffer severe liver problems .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use incruse ellipta every day . if you use more incruose ellipta than you should if you have used more inculse elliptas than you have been told to use , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may need to
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta stop taking this medicine and seek medical help immediately : itching skin rash ( hives ) redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination signs of a urinary tract infection such as common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead signs of inflammation of the sinuses ( sinusitis
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhaler in the sealed tray in order to protect from light . after removing the inhalcer from the sealed tray , use the inhal inhaler within 6 months . after using the inhaluer , use it within 30 . do away with the inhalER and dispose of it . do this for any other medicines you no longer use
what incruse ellipta contains - the active substance is umeclidinium bromide . each delivered dose contains 55 micrograms umecylidinia . each dose delivers 65 microgramms umecridinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incruere ellipta is an inhalation powder . the ellipta inhaler is supplied in a grey plastic body with a light green mouthpiece
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this type of protein is found in the body in patients with severe asthma . what nucalan is used for nucale is used in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type of white blood cell that helps the airways to open ) and affects the lungs . what is eosynophilic asthma ? asthma nucalo is used to prevent asthma attacks in adults who are already taking medicines called high dose inhalers to control
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 patients have experienced asthma - related side effects in the past . if your asthma is not controlled with nucal , your doctor may decide to stop nucale . if you think your asthma may be getting worse , talk to a doctor or go to the nearest hospital straight away . warnings and symptoms talk to the doctor or nurse before using nuca if you : are allergic
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week . the dose may be increased to 1 mg once a day . always use the pre - filled pen provided in the pack . do not shake nucala vigorously as this may affect its activity . duration of treatment with nucal your doctor will decide how long you should continue the treatment with this medicine . your doctor may decide to reduce the dose of nuca if your asthma symptoms get worse or if attacks occur . if your asthma symptoms get better
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms may be severe . symptoms may include chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to nucal . other side effects include :
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the nucalo pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator at 2 - 7 , but not above 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist
what nucala contains - the active substance is mepolizumab . each vial contains 1 ml of solution for injection ( equivalent to 100 mg of mepolizaumab ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale 1 ml solution for infusion is supplied as a pack containing 1 vial or as a multipack containing 3 vials of 1 ml . not all pack
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival and slowing down the number of myelomas cells . it also works by blocking a lot of proteins called proteasomes . what it does with ninlAR your doctor will tell you what you can do to help prevent multiple myelooma . how it works ninlero is given to adults with multiple my
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions : bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , tingling , numbness , swelling or a persistent rash . liver or kidney problems tell your doctor before starting treatment with ninlara if any part of the medicine gets worse during treatment , your doctor will do blood tests to check that you have enough
instructions for use in adults and adolescents with multiple myeloma : always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of ninlaro is lenalidomide ( a medicine that contains dexamethasone ), an anti - inflammatory medicine . the dose of each dose of the ninlara combination of lenalidomeide and dexamETHasone is 4 - week . you should take one dose of one dose in the morning and one dose on the same day of the week . the first 3 weeks of each 4 -
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the surface of the body ). rare side effects may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use it immediately . do this medicine if you notice any damage or signs of tampering to medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule contains 2 . 3 mg ixasomib citrate . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. what ninlar looks like and contents of the pack the capsule is white to off - white , capsule shaped , with " 3 " debossed on
do not use palforzia : if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfORzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palfiorzia is not intended to cause allergic reactions . palforbzia should not be used in children and young children under the age of 17 years . other medicines and palfourzia tell your doctor if you have or have had any other medical or
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of palforbzia ( listed in section 6 ). if your asthma is severe and you have a problem swallowing . if you have long term problems with your digestive system . if your doctor has told you that you have or have ever had a severe mast cell disorder . if any of these apply to you ( or you are not sure ), talk to your doctor . warnings and precautions talk to the doctor or pharmacist before taking palfourzia . the symptoms of peanut allergy may occur during treatment with palf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and frequency of administration if you have been treated for allergy , allergic reactions ( anaphylaxis ) have been reported in patients receiving palforzia . your doctor will determine the dose you need and will determine for how long you should take palferzia and for how many days . initial doseescalation and follow - up doses are given . your physician will prescribe the initial dose escalation and up - dosing steps that are best for you . if you take more palfourz
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of palforzia are severe allergic reactions . if you have any of the following symptoms after taking palfourzia , stop taking the medicine and seek medical help immediately : - trouble breathing - throat tightness - feeling offulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palfORzia may cause problems with the stomach and digestive system ( eosin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or particles in the vials . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfoforz . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcrycrystallinine celluloses , colloid anhydrated silica , magnesium stareate paforzias 300 mg oralpowder in sachet microcry crystalline cellulos , collaborhydrous siliconica and , magnesiumstearate , beige
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it is used to induce hypnotic actions in adults , adolescents and children . it has been prescribed for you by your doctor because you have sleeping problems . it should only be used when you are having treatment . if you are not able to tolerate treatment , you should contact your doctor . if your doctor thinks you may have problems sleeping , contact your physician .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zeren sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes very weak and tired muscles , severe breathing and chest problems ) if any of these apply to you , tell your doctor . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . other medicines and zerenea tell your
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , you should take the capsule at least one hour before or one hour after food . for patients aged 65 years and older with mild to moderate liver problems , the recommended starting dose is two 5 mg capsules per day . if your doctor determines that you have mild tomoderate liver problems and you take the 5 mg capsule at the same time , you may take the capsules at least two
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or nurse if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : ( affects fewer than 1 patient in 10, 000 ). not known ( frequency cannot be estimated from the available data ). very common : ( affecting
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . - capsule shell : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ). - printing ink : gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphates ( e133 ), silicon dioxide . printing ink ( s - 13050 ), shell
